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ABBREVIATIONS 
 
1D   one-dimensional 
2D   two-dimensional 
β3Gal-T  β1,3-galactosyltransferase 
β4Gal-T  β1,4-galactosyltransferase 
β3Gn-T  β1,3-N-acetylglucosaminyltransferase 
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C2GnT  core 2 β1,6-N-acetylglucosaminyltransferase 
cIGnT   centrally acting IGnT 
dIGnT   distally acting IGnT 
DQFCOSY  double quantum filtered correlated spectroscopy 
Fuc   L-fucose 
Gal   D-galactose 
GalNAc  N-acetyl-D-galactosamine 
Glc   D-glucose 
GlcNAc  N-acetyl-D-glucosamine 
HEV   high endothelial venules 
Hex   hexose 
HexNAc  N-acetylhexosamine 
HMQC  heteronuclear multiple quantum coherence 
HPAE   high-pH anion exchange 
IGnT   blood group I β1,6-N-acetylglucosaminyltransferase  
LacNAc  Galβ1-4GlcNAc  
Lc3Cer   lactotriosylceramide, GlcNAcβ1-3Galβ1-4Glcβ1-Cer 
Lea   Lewis a, Galβ1-3(Fucα1-4)GlcNAc 
Leb   Lewis b, Fucα1-2Galβ1-3(Fucα1-4)GlcNAc 
Lec   Lewis c, Galβ1-3GlcNAc 
Lex   Lewis x, Galβ1-4(Fucα1-3)GlcNAc  
MALDI-TOF MS matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry 
Neu5Ac  N-acetylneuraminic acid 
nLc5Cer  neolactopentaosylceramide, GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ1-Cer 
NMR   nuclear magnetic resonance  
PGC   polyglycosylceramide 
PLN   polylactosamine 
sLex   sialyl Lewis x, Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAc 
TOCSY  total correlation spectroscopy 
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SUMMARY 
 
Carbohydrates that cover cells have diverse biological functions. They function in cell 
differentiation, development, and aggregation of cells to form organs. Carbohydrate-binding 
proteins called lectins recognize specific carbohydrate structures and mediate cell-cell 
adhesion. For example, selectins guide leukocyte traffic to the sites of inflammation and their 
homing to lymph nodes. Processes such as fertilization and infection of cells by bacteria and 
viruses involve carbohydrates as well. In addition, many common diseases have turned out to 
be linked to specific glycosylation.  
Protein- and lipid-bound glycans commonly contain polylactosamine (PLN) chains. 
PLNs are composed of type 2 N-acetyllactosamine (LacNAc, Galβ1-4GlcNAc) units, which 
are coupled via β1-3 linkages to form a linear structure. Some of the Gal residues in the linear 
chain may be substituted with LacNAc units at the C-6 hydroxyl group forming a branched 
PLN. The linear and branched PLNs are known as blood group i and I antigen structures, 
respectively. PLNs form backbones for bioactive terminal epitopes, such as fucosylated and 
sialylated structures. Branching is biologically important since each branch may carry these 
epitopes, and the presentation of multiple epitopes enhances biological activity as compared 
to glycans with a single epitope.  
In this thesis, the conversion of linear PLNs to branched ones was studied. Blood 
group I β1,6-N-acetylglucosaminyltransferase activity of rat serum was shown to synthesize 
multiple GlcNAcβ1-6 branches to the midchain galactoses of linear PLNs. This type of 
branching activity has been termed centrally acting β1,6-N-acetylglucosaminyltransferase 
(cIGnT) activity as opposed to distally acting β1,6-N-acetylglucosaminyltransferase (dIGnT) 
activity, which transfers GlcNAc to the distal GlcNAcβ1-3LacNAc-R sequence. The 
cIGnT(s) converted LacNAcβ1-3LacNAcβ1-3LacNAc into a doubly branched glycan and 
successful β1,4-galactosylation of the GlcNAc-branches gave LacNAcβ1-3(LacNAcβ1-
6)LacNAcβ1-3(LacNAcβ1-6)LacNAc, a prototype of naturally occurring multiply branched 
polylactosamines. The triply branched LacNAcβ1-3(LacNAcβ1-6)LacNAcβ1-3(LacNAcβ1-
6)LacNAcβ1-3(LacNAcβ1-6)LacNAc structure was synthesized in a similar way. The triply 
branched glycan is a precursor for a tetravalent sialyl Lewis x (sLex, Neu5Acα2-3Galβ1-
4(Fucα1-3)GlcNAc) glycan that has been shown to inhibit L-selectin-mediated adhesion of 
lymphocytes to activated endothelium.  
In another part of the work, the IGnT from human embryonal carcinoma cell line PA1 
was functionally expressed and purified. The acceptor specificity study of IGnT showed that 
the enzyme possesses cIGnT type activity and is capable of forming multiple branches in a 
PLN acceptor.  
 In certain tissues, the type 1 disaccharide unit (Lec, Galβ1-3GlcNAc) is conjugated to 
the nonreducing end of PLNs. The β1,3-galactosyltransferase (β3Gal-T) activity present in 
human colon adenocarcinoma cell line Colo 205 was shown to β1,3-galactosylate different 
PLN acceptors in a fashion that corresponds to the naturally occurring type 1 epitope 
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structures. It was shown that branched type 1 epitopes, Lecβ1-3(GlcNAcβ1-6)LacNAc-R, 
may be synthesized by two alternative pathways; β3Gal-T may react with the prebranched 
acceptor or cIGnT (rat serum) may branch Lecβ1-3LacNAc-R.  
NMR spectroscopy was used in the structural analysis of the products together with 
enzymatic methods.   
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1. REVIEW OF THE LITERATURE 
 
1.1 Introduction to polylactosaminoglycan structures 
 
Poly-N-acetyllactosamines (PLNs, referred here as polylactosamines) form the backbone of 
many animal and some viral glycans, reviewed in the thesis of A. Leppänen [1], and bacterial 
glycans [2-4]. Linear polylactosamines consist of type 2 lactosamine (LacNAc, Galβ1-
4GlcNAc) units linked together by β1,3-linkages or more rarely by β1,6-linkages [5]. In 
branched polylactosamines, one or several galactose units are substituted with β1,6-linked 
GlcNAc or LacNAc units. Branches may be further extended with additional LacNAc units in 
linear or branched form. The type 1 lactosamine (Lec, Galβ1-3GlcNAc) unit may occur in the 
nonreducing terminus or internal positions of PLN chains. The expression of type 1 structures 
is restricted to epithelial tissues in humans (see section 1.3). N-acetyllactosdiamine 
(LacdiNAc, GalNAcβ1-4GlcNAc) unit occur at terminal ends of PLNs on vertebrate and 
invertebrate glycoproteins [6]. Examples of PLN structures are presented in Figure 1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polylactosamines can be attached to N-glycans and O-glycans of glycoproteins and 
glycolipids, and occur as free oligosaccharides in secretions. Complex type bi-, tri-, and 
tetraantennary N-glycans and four major O-glycan core types carry PLN chains (Figure 2). 
PLNs occur favorably on the Manα1-6 rather than the Manα1-3 arm of N-glycans [7]. In O-
glycans, PLNs usually occur on the β1,6-branch of core 2 or core 4 structures [8]. O-glycans 
usually carry PLNs that are composed of 1-3 LacNAc units [9-11], whereas N-glycans 
contain PLNs of three or more LacNAc units [12-14]. Proteoglycans carry keratan sulfates, 
sulfated linear polylactosamines that are N- or O-linked to the protein [15]. In glycolipids, 
polylactosamines are formed on lactosylceramides (LacCer, Galβ1-4Glcβ1-Cer). LacCer is 
Galβ1-4GlcNAc 3 6
Galβ1-4GlcNAcβ1 
Galβ1-4GlcNAcβ1 
3 
6 
Galβ1-4GlcNAcβ1 
Galβ1-4GlcNAc 3 
Galβ1-4GlcNAcβ1 3 
Galβ1-4GlcNAcβ1 
Galβ1-4GlcNAc 3 6
             GlcNAcβ1 
Galβ1-4GlcNAcβ1 
3 
 Galβ1 
Linear polylactosamine 
Branched polylactosamine 
Branched polylactosamine composed of  
type 1 and type 2 disaccharide units 
Figure 1. Examples of linear and branched polylactosamine structures. 
Galβ1-4GlcNAcβ1 
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elongated with LacNAc or Lec units and the corresponding core structures are called neolacto 
(nLc) and lacto (Lc) series, respectively [16]. Glycolipids that have large glycans (about 20-
50 monosaccharides) are called polyglycosylceramides (PGCs) [17, 18]. Human milk [19] 
and seminal plasma [20] contain significant amounts of free oligosaccharides. PLN chains in 
milk are attached to lactose (Lac, Galβ1-4Glc) and those in seminal plasma to GlcNAcβ1-
3/4Glc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The biological activity and heterogenity of polylactosamines is provided by the degree 
of polylactosamine elongation and branching, in addition to different mosaccharide units 
linked to internal and terminal positions. Linear chains are frequently terminated by 
functional, often cell-type specific structures, such as the blood group ABO antigens and 
Lewis antigens (Figure 3). Internal GlcNAc units may be α1,3-fucosylated. The branched 
chains carry terminal groups on the branches as well.  
 
 
 
 
 
 
3 GalNAcα1-Ser/Thr 
GlcNAcβ1 
6
GlcNAcβ1 
3 GalNAcα1-Ser/Thr 
Galβ1 
3 GalNAcα1-Ser/Thr 
Galβ1 3 
GalNAcα1-Ser/Thr 
GlcNAcβ1
Core 1 
Core 2 
Core 3
Core 4 
O-glycan cores 
Complex type 
N-glycan core 
Figure 2. The structures of N-glycan and O-glycan cores that carry polylactosamine chains. For N-
linked glycan the possible side chains are marked with arrowheads. A tetraantennary N-glycan
contains all four side chains, a triantennary one may contain R-GlcNAcβ1-2 and R-GlcNAcβ1-6 side
chains and is called 2,6-branched, or R-GlcNAcβ1-2 and R-GlcNAcβ1-4 chains when it is called 2,4-
branched. A biantennary N-glycan has R-GlcNAcβ1-2 side chains. 
6
3 
2 
R-GlcNAcβ1 
Manα1 6
R-GlcNAcβ1
Manβ1-4GlcNAcβ1-4GlcNAcβ1-Asn                        
     4Manα1 R-GlcNAcβ1
2 
    R-GlcNAcβ1 
6 
GlcNAcβ1 
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1.2 Expression of branched polylactosaminoglycans  
 
The human blood group i and I antigens are characterized as linear and branched 
polylactosamines LacNAcβ1-3LacNAc-R and LacNAcβ1-3(LacNAcβ1-6)LacNAc-R, 
respectively [21-23]. Ii antigens are present in erythrocytes, various tissues and body fluids, 
and they are recognized as histo-blood group antigens [24-26]. The expression of Ii antigens 
is developmentally regulated in human erythrocytes and other tissues including epithelia, and 
during mouse embryogenesis [26, 27].  
 
 
1.2.1 Developmentally regulated expression in human erythrocytes 
 
Fetal and neonatal erythrocytes contain predominantly i antigens. The expression of i antigens 
decreases after birth, while the expression of I antigens increases until adult I antigen level is 
reached at 18 months [28, 29].  
High molecular weight glycopeptides from adult erythrocytes were found to contain 
large and multiply branched N-linked PLNs that carry blood group epitopes [30-32]. At the 
same time, the anion transport (band 3) and glucose transport (band 4.5) glycoproteins, and 
glycolipids were shown to be carriers of Ii and blood group antigens on erythrocytes, band 3 
being the major carrier [33-35]. One of the major lactosaminoglycans on fetal band 3 is a bi-
antennary N-glycan carrying a linear polylactosamine of six LacNAc units on the Manα1,6-
arm and a shorter chain on the Manα1,3-arm. The longer chain may be capped with Fucα1,2 
or Neu5Acα2,3 residue, whereas the shorter chain contains Neu5Acα2,6 residue [36]. Adult 
band 3 polylactosamine chains are a few LacNAc units longer and uniformly branched with 
LacNAc units. Typically, one or more unbranched LacNAc units are located between the 
branched ones. Fucosylation and sialylation take place preferentially at the terminal region 
Galβ1-3/4GlcNAcβ1-R 
Fucα1 
2 
Fucα1 
Galβ1-3/4GlcNAcβ1-R 3 
             GalNAcα1 2 
 
Galβ1-3/4GlcNAcβ1-R 3 
                    Galα1 
Fucα1 
2 
H 
A 
B 
Lex
3 
                    Fucα1              Neu5Acα2
Galβ1-4GlcNAcβ1-R 
3 
sLex 
Ley
Lea 
sLea 
Leb
Figure 3. Structures of the blood group A, B, O(H), Lea, and Leb and other Lewis antigenic 
determinants. 
Galβ1-4GlcNAcβ1-R 
3 
Fucα1 
Fucα1
2 
Galβ1-4GlcNAcβ1-R 
3 
Fucα1
Fucα1-4GlcNAcβ1-R 
3 
Galβ1 
Fucα1-4GlcNAcβ1-R 
3 
Neu5Acα2 
3
Galβ1 
3 
Galβ1 
Fucα1-4GlcNAcβ1-R 
Fucα1 
2 
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[12]. The number of terminal substitutions changes during erythrocyte maturation: α2,3-
sialylation decreases and α1,2-fucosylation increases [7]. The polylactosamine chains of adult 
band 4.5 are similar to those of band 3, except that the number of branches and blood group 
determinants is smaller [37]. Another major glycoprotein on the erythrocyte membrane, 
glycophorin A, is differently glycosylated from band 3 and 4.5. Glycophorin A lacks 
polylactosamines, but instead contains single α2,6-sialylated LacNAc units linked to a 
biantennary N-glycan core and α2,3- and/or α2,6-sialylated core 1 O-glycans [38, 39]. 
The polylactosamines of glycolipids also change during erythrocyte maturation. Both 
neutral and acidic glycolipids of newborn and fetal erythrocytes contain smaller quantities of 
long PLN chains, and chains are more sialylated and less branched than in adult erythrocytes 
[40-42]. The branched glycolipid structures of adult erythrocytes have been characterized as 
(LacNAcβ1-3)1-2(LacNAcβ1-6)LacNAcβ1-3(LacNAcβ1-3)0-1Lacβ1-Cer. The terminal Gal 
residues are capped with Fucα1,2 and Galα1,3 or GalNAcα1,3 residues depending of the 
blood group [43-45]. Larger, branched polylactosamines with blood group epitopes are 
present on polyglycosylceramides (PGCs) that comprise up to 60 saccharide residues per 
ceramide [17]. Lex and Ley epitopes on PGCs have been detected in minor amounts [18].  
The binding of anti-ABO antibodies to infant erythrocytes, which are deficient of 
branched ABH blood group active polylactosamines, has been shown to be relative weak as 
compared to the binding to adult erythrocytes, which present bivalent ABH determinants. 
Thus, it has been suggested that the lack of branched bivalent ABH determinants in the fetus 
may have a protective effect in an ABO-incompatible pregnancy [46]. 
 
 
1.2.2 Cell type specific expression 
  
Erythrocytes and granulocytes directly differentiate from the same precursor stem cells. In 
contrast to adult erythrocytes, granulocytes express only linear polylactosamines on 
tetraantennary N-glycans [13, 47], core 2 based O-glycans [9], and glycolipids [48, 49]. PLN 
chains bound to N-glycans and glycolipids may be polyfucosylated, capped with Neu5Acα2,3 
or Neu5Acα2,6 residues, and form Lex and sLex determinants [13, 47-49]. O-glycans, which 
are mainly derived from leukosialin (CD43), are elongated at the core β1,6-branch 
predominantly with one LacNAc unit and have Neu5Acα2,3 residues at the terminal ends. 
Minor O-glycans contain 2-3 repeating LacNAc units on the core β1,6-branch, and some O-
glycans carry the sLex epitope [9]. Among the blood cells, only granulocytes and monocytes 
are enriched with Lex and sLex structures, whereas the ABO blood group antigens are 
restricted to erythroid cells. 
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1.2.3 Expression in embryonic cells 
 
Embryonal carcinoma (EC) cells are undifferentiated stem cells that resemble the cells in the 
early embryo, and have been used as a model in studies of early embryogenesis [50].  
Glycopeptides containing unusual large oligosaccharides composed of LacNAc-
repeats have been identified from human teratocarcinoma-derived EC cells, PA1 [51, 52]. 
Detailed structural analysis of the glycans has shown that they are branched polylactosamines 
attached to tri- and tetraantennary N-glycan cores. The PLN chains contain 10-18 LacNAc 
units in linear form and 25-40% of the galactose units are branched with LacNAc units. Their 
nonreducing ends are substituted with Neu5Acα2,3/α2,6 residues or with the disialyl 
structure Neu5Acα2-9Neu5Acα2-3/6. Notably, no fucosylation has been detected [14]. 
Glycolipids characterized from PA1 cells contain short, unbranched glycans, for example 
Galβ1-3/4GlcNAcβ1-3Lac-Cer capped with  Neu5Acα2,3/α2,6 residues [53].  
Mouse EC cells and early embryonic cells have protein-bound large glycans that 
contain highly branched and terminally fucosylated PLNs [54, 55]. The protein-carbohydrate 
linkage appears to be N-glycosidic [55, 56]. During the differentiation of EC cells, the large 
glycopeptides disappear almost completely [54]. Consistently, undifferentiated EC cells 
express mainly I antigen and differentiated cells i antigen [57, 58]. In the course of mouse 
embryogenesis, I antigen is expressed in the early embryonic cells throughout the 
preimplantation period, whereas i antigen is first detected in the differentiated cells of the 5-
day embryo [57, 59]. The high-molecular weight glycoproteins of EC cells carry the I/i 
antigens and the stage-specific embryonic antigen-1, SSEA-1 [58]. The antigenic determinant 
of SSEA-1 is Lex [60]. SSEA-1 is expressed in undifferentiated EC cells and appears in 
mouse eight-cell embryos, but disappears from differentiated EC cells and embryonic cells 
during embryogenesis [58, 61]. Oligosaccharides with Lex determinant(s) have been shown to 
inhibit mouse embryo compaction in vitro, suggesting that SSEA-1 might participate in the 
adhesive events of preimplantation embryogenesis [62, 63]. 
 
 
1.2.4 Branched polylactosamines from other sources 
 
The increased expression of branched PLNs in N-glycans has been detected in some cells 
after malignant transformation. Highly metastatic human colon carcinoma cells express more 
PLN side chains with branched galactose residues than cells with low metastatic potential 
[64]. Human thyroglobulin from malignant thyroid tissues carries high-molecular mass 
oligosaccharides, which are likely to contain highly branched PLNs, whereas normal thyroid 
tissues lack analogous oligosaccharides [65].  
Branched PLNs play roles in cellular interactions. Laminin is a high molecular weight 
glycoprotein that occurs in the basement membranes of a variety of tissues and has been 
shown to interact with the cell adhesion proteins galectin-1 and galectin-3 [66, 67]. Laminin 
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from the murine Engelbreth-Holm-Swarm (EHS) tumor has been shown to contain both linear 
and branched PLNs linked to biantennary N-glycans [68]. Mouse uterine epithelial cells 
express N-linked PLNs that are involved in cell adhesion processes [69]. Estrogen stimulates 
PLN synthesis in uteri, and the resulting PLNs may be highly branched [70]. The surface of 
the parasitic prozoan Tryponosoma brucei is covered with a single species of the variant 
surface glycoprotein (VSG), which protects the organism against lysis by host serum 
components. Type II VSG expresses branched PLNs on a biantennary N-glycan [71]. 
O-glycans of human gastric [72, 73], colonic [74, 75], and bronchial mucins [76], and 
milk secretory IgA [77] contain singly branched PLNs. In addition, O-glycans of rat colonic 
[78] and swine tracheal mucins [79, 80], and pig stomach cell linings [81] bear branched 
PLNs. Glycolipids that carry singly branched PLNs are present in human myelogenous 
leukemia cells (HL-60) as minor components [82], hog gastric mucosa [83], and epithelial 
cells of rat small intestine [84, 85]. A structure where the branch is branched again has been 
characterized from hog gastric mucosa [86]. The branched PLNs linked to O-glycans and 
glycolipids in mucin producing tissues contain variably type 1 or type 2 units next to the 
branched galactose residue, Galβ1-3/4GlcNAcβ1-3(GlcNAcβ1-6)Gal-R. Human milk glycans 
contain also terminal type 1 units. Human PLNs with terminal type 1 units are discussed in 
section 1.3. 
 In addition to human erythrocytes, branched PLNs occur on rabbit and bovine 
erythrocytes. The glycolipids of rabbit erythrocytes contain 1-7 repeated branched LacNAc 
units [87-89], but a glycolipid structure with only one branched unit has been characterized 
from bovine erythrocytes [22]. In both species, the LacNAc-branches are capped with 
Galα1,3 residues and in rabbit, the terminal end is capped with Galα1,3 residue [87-89] and 
in bovine with Neu5Acα2,3 residue [22]. In contrast to human glycophorin A, which lacks 
PLN, the O-glycans of bovine glycophorin contain 1-2 LacNAc units in a linear form and 
branched LacNAcβ1-3(LacNAcβ1-6)LacNAc structures. The PLNs of bovine glycophorin 
are also capped with Galα1,3 or Neu5Acα2,3 residues [90, 91]. 
Polyglycosylceramides with highly branched PLNs, in addition to those present in 
erythrocytes, have been found in human placenta [92], rabbit small intestine [93], and the 
pancreatic carcinoma cell line PANC-1 [94]. 
 
 
1.3 Expression of polylactosaminoglycans with terminal type 1 unit  
 
Expression of the Galβ1-3GlcNAc (Lec) disaccharide, also called type 1 unit, at the 
nonreducing terminus of PLNs is restricted to the epithelia of the gastrointestinal tract, other 
mucin-producing tissues, and human milk. Usually type 1 units are substituted and present 
ABH, Lea, or Leb blood group antigens. Table 1 presents type 1 epitopes derived from human 
polylactosaminoglycans. 
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Table 1. The structures, origin, and carriers of type 1 epitopes characterized from human. 
 
Type 1 epitope structures Origin Carriers References 
 
Gastric  
-mucina) 
-mucosa and epithelium 
 
 
Core 1 and 2 based O-glycans 
Glycolipids 
 
 
[72, 73] 
[108, 109] 
 
Colonic  
-mucin 
-epithelial cells 
 
 
Core 3 based O-glycans 
Mono- to tetra-antennary N-
glycans (NFA-2) b) 
Glycolipids 
 
[74, 75] 
 
[97] 
[98] 
Small intestinal epithelial 
cells 
Tri- and tetra-antennary N-
glycans  
Glycolipids 
 
[95] 
[95, 99] 
Foetal gastrointestinal 
(meconium) 
-mucins 
-mucosal cells 
- epithelial cells 
 
 
Core 2 and 3 based O-glycans 
Glycolipids 
Bi- to tetra-antennary N-glycans 
(NCA-2) c) 
 
 
[110] 
[111] 
 
[96] 
Ovarian cyst mucins Core 1, 2 and 6d) based O-
glycans 
 
[101, 102] 
Amniotic mucins Core 2 based O-glycans [112] 
Bronchial mucin Core 2 and 4 based O-glycans [76, 103] 
 
 
 
Milk 
 
Free oligosaccharides 
Core 2 based O-glycans of IgA 
Core 1 and 2 based O-glycans of 
β4Gal-T 
[104, 105] 
[77] 
 
[5] 
Gastric mucina) Core 1 and 2 based O-glycans [72, 73] 
Colonic mucin Core 3 based O-glycans [74] 
Ovarian cyst mucins Core 1 and 2 based O-glycans [101, 102] 
Bronchial mucin Core 1 and 2 based O-glycans [76] 
 
 
 
 
Milk 
 
Free oligosaccharides 
Core 2 based O-glycans of IgA 
[104, 106] 
[77] 
 
Gastric mucina) 
 
Core 1 and 2 based O-glycans 
 
[72, 73] 
 
Colonic mucin Core 3 based O-glycans [74, 75] 
 Milk  
 
Core 1 based O-glycans of 
β4Gal-T 
 
[5] 
a) The terminal units have been characterized as Galβ1-3/4GlcNAc, type 1 unit beeing predominant  
b) Normal faecal antigen-2 
c) Nonspecific cross-reacting antigen-2 
d) GlcNAcβ1-6GalNAc 
 
 
 
Galβ1-R 3 
             GlcNAcβ1 3 
                     Galβ1 
Galβ1-R 3 6 
             GlcNAcβ1 
Galβ1-4GlcNAcβ1 
3 
                     Galβ1 
Galβ1-R 3 6 
             GlcNAcβ1 
GlcNAcβ1 
3 
Galβ1 
3 
                     Galβ1 
Galβ1-R 6 
GlcNAcβ1 3 
                     Galβ1 
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Structural characterization of O-glycans from gastric mucins has indicated that the 
glycans are mainly branched and type 1 units are predominant at the distal ends [72, 73]. The 
O-glycans from colonic mucins are linear or branched derivatives of the linear structures. 
Type 1 and type 2 units are variably present at terminal ends [74, 75]. The largest O-glycans 
in gastric and colonic mucins contain four and three Lec/LacNAc units, respectively [72-75]. 
N-linked glycopeptides representing a major part of the glycans in small intestinal epithelial 
cells have been isolated and shown to bear Lec, LacNAc, or LacNAcβ1-3LacNAc sequences. 
Type 2 units are predominant, and on the average, one type 1 unit is present in one N-glycan. 
However, glycolipids from the same cells contain mainly type 1 determinants [95]. In adults, 
colon epithelial cells express normal faecal antigen-2 (NFA-2) and in fetuses nonspecific 
cross-reacting antigen (NCA-2), which are counterparts of carcinoembryogenic antigen 
(CEA) produced by colon adenocarcinomas. About 75% of the sugar chains of NFA-2 and 
34% of NCA-2 contain type 1 units in their outer chain moieties, but only trace amounts are 
present in CEA. The side chains of NCA-2 and NFA-2 also contain repeating Lec/LacNAc 
units [96, 97]. Lactotetraosylceramide (Lecβ1-3Lacβ1-Cer) is one of the major glycolipid 
components in colon and small intestine [95, 98, 99], whereas the isomeric LacNAcβ1-
3Lacβ1-Cer is present only in trace amounts [98, 99]. Larger glycolipids, composed of 9-10 
monosaccharide units, have been found from small intestine. They are branched, fucosylated, 
and carry terminal type 1 units [100]. 
O-glycans from ovarian cyst mucins have terminal type 1 units and repeating type 1 
units, Galβ1-3GlcNAcβ1-3Galβ1-3GlcNAcβ1-R [101, 102], which may be branched from 
Gal (underlined) [101]. O-glycans of respiratory mucins have been isolated and characterized 
from a patient suffering from bronchiectasis. Four common elements exist in these O-glycans: 
Lec/LacNAcβ1-3LacNAcβ1-6(GlcNAcβ1-3)GalNAc and Lec/LacNAcβ1-3(LacNAcβ1-
6)Galβ1-3GalNAc [76, 103]. 
Free oligosaccharides in human milk contain linear and branched PLNs that are 
composed of type 2 units and have terminal type 1 or 2 units [104, 105]. The largest 
characterized structure is LacNAcβ1-6(Lecβ1-3)LacNAcβ1-6(Lecβ1-3)Lac where the first 
branch linked to the lactose is branched again [106]. Larger oligosaccharides exist in milk, but 
they have not been characterized in detail [107]. 
 
 
1.4 Biosynthesis of polylactosaminoglycans 
 
The biosynthesis of oligosaccharides is mainly carried out by enzymes called 
glycosyltransferases in the Golgi apparatus. Golgi glycosyltransferases are type II 
transmembrane proteins. They have a short amino-terminal domain placed in the cytosol, a 
membrane-spanning domain, and stem- and carboxy-terminal catalytic domains in the Golgi 
lumen. Soluble glycosyltransferases in secretions and body fluids are derived from their 
membrane-associated forms by proteolytic cleavage at the stem region.  
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Glycosyltransferases transfer sugar moieties from activated donor sugars (e.g. UDP-
GlcNAc, UDP-Gal) to specific acceptor molecules. Linear polylactosamines are synthesized 
by the alternating action of β1,3-N-acetylglucosaminyltransferases (β3Gn-Ts) and β1,4-
galactosyltransferases (β4Gal-Ts). The terminal galactose may alternatively be transferred by 
a β1,3-galactosyltransferase (β3Gal-T), forming a β1-3 linkage to the terminal GlcNAc of 
PLN. Blood group I β1,6-N-acetylglucosaminyltransferases (IGnTs) transfer GlcNAc in β1-6 
linkage to linear PLNs forming branched PLNs.  
During recent years, a number of new glycosyltransferase genes have been identified 
from human genomic sequence databases. β3Gn-T, β4Gal-T, β3Gal-T, and IGnT families 
have been shown to include several members. Individual members may exhibit differences in 
substrate specificity, kinetic parameters, and expression patterns, and their genes may be 
differently regulated. For references of the glycosyltransferase families, see [113, 114]. 
 
 
1.4.1 β1,3-N-acetylglucosaminyltransferases 
 
β1,3-N-acetylglucosaminyltransferase (β3Gn-T) activities are found in several cells, tissues, 
and body fluids of humans [115-120] and other animals [121-124]. The β3Gn-T activities 
have shown to elongate free Lac(NAc) [115-117, 124] and different types of oligosaccharide 
acceptors [115, 116, 123, 124], N-linked glycoproteins [116, 121], and glycolipids [118-120, 
122] that contain terminal Lac(NAc) unit. Human serum contains activities for all these 
substrates, and in addition, for desialylated and defucosylated O-glycans of mucins and 
keratan sulfate [116]. 
The partially purified β3Gn-T from Novikoff tumor cell ascites fluid elongates 
LacNAc and different oligosaccharide acceptors that present LacNAc-Man sequences. 
Optimal activity is encountered with the Galβ1-4GlcNAcβ1-2(Galβ1-4GlcNAcβ1-6)Man 
pentasaccharide acceptor. Asialo α1-acid glycoprotein, containing the pentasaccharide 
structure on N-linked glycans, is a much better acceptor than asialofetuin and 
asialotransferrin, which are N-glycoproteins deficient of that structure [125]. The β3Gn-T 
purified from calf serum has similar specificity for N-glycoproteins [126]. The partially 
purified human serum β3Gn-Ts transfer GlcNAc more efficiently to LacNAc and asialo α1-
acid glycoprotein than to Lac [127]. 
Some β3Gn-T activities [117, 118, 124] and the β3Gn-Ts purified from human serum 
[127] transfer GlcNAc to acceptors that have terminal type 1 unit, Galβ1-3GlcNAc, but the 
transfer rate is much lower than the transfer rate to Galβ1-4GlcNAc. The β3Gn-T from calf 
serum has no activity to type 1 acceptor [126]. α1,2-fucosylation of terminal Gal or α1,3-
fucosylation of subterminal GlcNAc blocks the β3Gn-T reaction [116-118, 124, 126]. 
Seven human β3Gn-Ts (iGnT, β3Gn-T2-T7) have been identified to date and six of 
them (iGnT, β3Gn-T2-T6) have been cloned and characterized [128-132]. The i-extension 
enzyme (iGnT) elongates polylactosamines. The iGnT transcript is ubiquitously expressed in 
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various adult tissues, and especially highly in adult brain and in fetal brain and kidney [128]. 
β3Gn-T2-T7 have been found to be structurally similar to the members of the β1,3-
galactosyltransferase family, but differ from iGnT [129-132]. The β3Gn-T2 and β3Gn-T5 
transcripts are ubiquitously expressed in tissues and cells, whereas the expression of β3Gn-T3 
is restricted to colon, jejunum, stomach, esophagus, placenta, and trachea, and β3Gn-T4 is 
mainly expressed in the brain [129, 130]. iGnT, β3Gn-T2, and -T4 prefer LacNAcβ1-3Lac to 
Lecβ1-3Lac, whereas β3Gn-T3 utilizes both substrates at a comparable rate [128, 129]. 
Transfection of Namalwa KJM-1 cells with β3Gn-T2, -T3, or -T4 cDNAs has indicated that 
these enzymes are able to initiate and elongate polylactosamine synthesis in vivo [129]. β3Gn-
T5 has been identified as Lc3Cer synthase as it transfers GlcNAc to lactosylceramide. β3Gn-
T2, -T3, and -T4 do not react with LacCer [130]. The β3Gn-T6 transcript is mainly expressed 
in stomach, colon, and small intestine. β3Gn-T6 transfers GlcNAc to GalNAc forming the 
core 3 structure of O-glycans [131]. 
 
 
1.4.2 β1,4-galactosyltransferases 
 
Early studies have shown that bovine milk β1,4-galactosyltransferase (β4Gal-T) transfers 
galactose to GlcNAc, but in the presence of α-lactalbumin, the transfer to GlcNAc is inhibited 
and the enzyme preferentially acts as lactose synthase [133, 134]. Acceptor specificity studies 
have shown that bovine milk β4Gal-T reacts preferentially to the GlcNAcβ1,6-branch of the 
acceptors GlcNAcβ1-3(GlcNAcβ1-6)Gal-R, where R is H, GlcNAc, Glc, Glc-OMe, or 
GlcNAcβ1-6(Galβ1-3)GalNAc-ol [135-138].  
 β4Gal-T1 is abundant in bovine and human milk in a soluble form, and is the first 
galactosyltransferase for which the corresponding cDNA has been isolated [139]. To date, 
seven members of the human β4Gal-T family (β4Gal-T1-T7) have been identified, reviewed 
in [140]. β4Gal-T2 is affected by α-lactalbumin in a similar manner to bovine milk β4Gal-T 
(β4Gal-T1) [141]. β4Gal-T1 has been shown to elongate more efficiently linear PLN chains 
and the GlcNAcβ1,6-branch than β4Gal-T2-T5 [142]. β4Gal-T1 is also most efficient in 
adding galactose to GlcNAcβ1-6/2Manα1-6Manβ1-octyl, and in addition, it prefers β1,6-
linked GlcNAc [143, 144]. β4Gal-T1 galactosylates most efficiently O-glycan core 4 branch 
but poorly core 2 branch [143, 145]. Core 2 branch is utilized by β4Gal-T4 [143]. O-glycan 
core 2 and core 6 (GlcNAcβ1-6GalNAc) have been shown to be the best substrates for β4Gal-
T5 [146]. β4Gal-T3 and -T4 catalyze the transfer of galactose to lactoseries glycolipids 
(Lc3Cer, nLc5Cer). Both enzymes have shown a strong preference for Lc3Cer over nLc5Cer 
[141, 147]. β4Gal-T6 synthesizes lactosylceramide [148], and β4Gal-T7 galactosylates xylose 
attached to proteoglycan core proteins [149, 150]. 
The expression of human β4Gal-T1-T6 mRNAs has been comparatively analyzed 
[151]. β4Gal-T1 and β4Gal-T3 are widely expressed, but only β4Gal-T3 is expressed in high 
levels in the brain. β4Gal-T4 and -T5 are also widely expressed but in lower levels than 
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β4Gal-T1 and -T3. Expression of β4Gal-T2 is restricted to fetal brain and adult heart, muscle, 
and pancreas. β4Gal-T6 is expressed only in adult brain. The fact that only the β4Gal-T1 gene 
is expressed in murine lactating mammary glands indicates that β4Gal-T1 but not β4Gal-T2 is 
responsible for lactose synthesis in lactating mammary glands. 
 
 
1.4.3 β1,3-galactosyltransferases 
 
Α β1,3-galactosyltransferase (β3Gal-T) has been first detected from pig trachea [152]. The 
purified enzyme β1,3-galactosylated GlcNAc, GlcNAcβ1-3Lac, O-glycan core 3, and 
lactotriosylceramide (Lc3Cer) [153]. The β3Gal-T activity present in Colo 205 cells has also 
been shown to β1,3-galactosylate GlcNAc [154] and Lc3Cer [155].  
A family of six human β1,3-galactosyltransferases (β3Gal-T1-T6) have been cloned to 
date [156-159]. Three of them, β3Gal-T1, β3Gal-T2, and β3Gal-T5, catalyze the synthesis of 
the type 1 structure [156-158]. β3Gal-T5, originally cloned from Colo 205 cells, has activity 
toward GlcNAc, Lc3Cer, O-glycan core 3, and also to the terminal GalNAc of globoside 
(Gb4, GalNAcβ1-3Galα1-4Galβ1-4Glcβ1-Cer) [160-162]. β3Gal-T1 and β3Gal-T2 react 
with GlcNAc, Lc3Cer, and nLc5Cer, but not with Gb4 [156, 157]. All three β3Gal-Ts are 
active in some extent on GlcNAcβ1-2/4/6Man substrates [157, 160, 162], but at least β3Gal-
T5 prefers the GlcNAcβ1-3Galβ1-R (R=OMe or Glcβ1-Cer) acceptor sequence [162]. 
Studies of β3Gal-Ts tissue distribution have shown that β3Gal-T1 and β3Gal-T2 are 
expressed in brain and at least in some extent in colon, and in addition β3Gal-T2 is expressed 
in heart [156, 157, 162]. Substantial β3Gal-T5 expression has been detected in colon, 
stomach, jejunum, and pancreas [158]. 
 
 
1.4.4 β1,6-N-acetylglucosaminyltransferases 
 
β1,6-N-acetylglucosaminyltransferases (β1,6GnTs) are classified according to their substrate 
specificities. Blood group I β1,6-N-acetylglucosaminyltransferases (IGnTs) generate 
GlcNAcβ1,6-branches on linear polylactosamines. O-glycan core branching enzymes convert 
core 1 to core 2 structure [Galβ1-3GalNAc −> Galβ1-3(GlcNAcβ1-6)GalNAc] and core 3 to 
core 4 structure [GlcNAcβ1-3GalNAc −> GlcNAcβ1-3(GlcNAcβ1-6)GalNAc] and are called 
core 2 and core 4 β1,6-N-acetylglucosaminyltransferases (C2GnT, C4GnT), respectively. 
β1,6-N-acetylglucosaminyltransferase V (GnTV) synthesizes a GlcNAcβ1,6-branch to 
GlcNAcβ1-2Manα1-6Man in N-glycan core. None of the β1,6GnTs have requirements for 
Mn2+ ions, whereas β3Gn-Ts require divalent metal ions for full activity. 
Two types of IGnTs with different acceptor site specificities have been characterized. 
The distally acting IGnT (dIGnT) acts on the subterminal Gal residue of the PLN chain. The 
centrally acting IGnT (cIGnT) transfers GlcNAc to the midchain Gal residues of completed or 
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growing PLN chains (Figure 4). A β1,6GnT activity that transfers GlcNAc to terminal 
galactose (tIGnT) has been reported [121, 122, 163, 164], but this type of activity has not 
been detected in any of the purified or cloned enzymes. 
 
 
 
 
 
 
 
 
 
 
 
1.4.4.1 Distally acting β1,6-N-acetylglucosaminyltransferases 
 
Distally acting IGnT activity has been detected in hog gastric mucosa [165, 166], in Novikoff 
ascites tumor cells [164], and in a partially purified rat intestine enzyme [123]. All 
characterized dIGnTs transfer GlcNAc to terminal GlcNAcβ1-3Gal units of oligosaccharides, 
and the substitution of the terminal GlcNAc by galactose blocks the transfer reaction [123, 
165]. Rat intestine and hog gastric dIGnTs have been shown to branch only the subterminal 
Gal (underlined) in GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc-PA/GlcNAc acceptors, 
indicating that dIGnTs do not branch midchain galactoses [123, 167]. Enzymes purified to 
apparent homogenity from bovine trachea [168] and rat small intestine [169] possess three 
different but related activities: core 2 and 4 branching activities, and dIGnT activity 
(C2GnT/C4GnT/dIGnT activities).  
Three human C2GnT enzymes have been cloned: C2GnT-leukocyte type (C2GnT-L, 
C2GnT1) [170], C2GnT-mucin type (C2GnT-M, C2GnT2) [171, 172], and C2GnT3 [173]. 
C2GnT1 and C2GnT3 have only C2GnT activity [170, 171, 173], whereas C2GnT2 has 
C2GnT/C4GnT/dIGnT activities [171, 172]. C2GnT2 transcripts are heavily expressed in 
mucin producing tissues [171]. An ortholog of C2GnT2 that also has C2GnT/C4GnT/dIGnT 
activities has been identified in bovine herpes virus type 4 (pBORFF3-4, v-C2GnT2) [174]. 
The cDNA corresponding to the purified rat small intestine dIGnT has been cloned, and the 
rat dIGnT has been indicated to be an ortholog of human and viral C2GnT2s [169]. Human 
and viral C2GnT2s exhibit the strongest activities as C2GnTs, moderate activities as C4GnTs, 
and weakest activities as dIGnTs [171, 174]. In contrast, rat and bovine dIGnTs contain 
comparable amounts of C2GnT and C4GnT activities and lower but significant amounts of 
dIGnT activity [168, 169]. A weak dIGnT activity has been detected in human cIGnT 
(IGnT1) [142, 171] and C2GnT3 [173], and a very weak cIGnT activity has been observed in 
human and viral C2GnT2s [171, 174]. 
Galβ1-4GlcNAcβ1-R 3 
Galβ1-4GlcNAcβ13 
  GlcNAcβ1 
dIGnT 
cIGnT
Figure 4. Site-specificity of distally and centrally acting blood group I β1,6-N- 
acetylglucosaminyltransferases. 
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1.4.4.2 Centrally acting β1,6-N-acetylglucosaminyltransferases 
 
Centrally acting IGnT activity has been detected for the first time in human serum [175], in 
rat tissues and serum [123, 176], and in a partially purified rat intestine enzyme [123]. These 
cIGnTs have been demonstrated to form GlcNAcβ1,6-branch to the internal galactose residue 
in Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAc/Glc acceptors. The cIGnT activity present in rat 
serum and several other mammalian sera has also been shown to form multiple branches to 
linear PLNs (publication I, this thesis). A cIGnT enzyme, which also generates multiple 
branches to PLNs, has been purified from hog small intestine [177]. 
The cDNA encoding IGnT has been first cloned from human embryonal carcinoma 
cells, PA1 [178]. A fusion protein with glutathionesulfotransferase (GST)-IGnT has been 
functionally expressed and purified (publication III, this thesis). The analysis of the substrate 
specificity of the GST-IGnT using free polylactosamines as acceptors has indicated that the 
enzyme possesses cIGnT type activity, but not dIGnT type activity (publication III, this 
thesis), which is in accordance with the activity present in PA1 cells [179]. However, some 
dIGnT activity has been observed in analogous recombinant protein A-IGnT when the 
polylactosamine acceptor is linked to a Manα1-6Man derivative [142, 171]. Also very weak 
C2GnT and C4GnT activities have been detected in protein A -IGnT [171]. 
The first IGnT has been designated IGnT1 (IGnT6 in publication III) after 
demonstration that the human I locus codes also two other IGnT forms, designated IGnT2 and 
IGnT3 [180]. The IGnT1-T3 forms have also been called IGnTB, IGnTA, and IGnTC, 
respectively [181]. IGnT1 and IGnT2 transcripts are expressed in many adult and fetal tissues 
ubiquitously, but IGnT1 is expressed at lower levels than IGnT2. IGnT3 is strongly expressed 
in bone marrow, heart, stomach, and small intestine. IGnT3 has been indicated to be the most 
feasible candidate for the expression of the blood group I antigen in erythrocytes, because the 
expression of the IGnT3 transcript is markedly increased during erythrocyte differentiation, 
and IGnT3 is the most strongly expressed IGnT in erythrocytes [180]. In mammary gland, the 
highest transcript level has been detected for IGnT2, and this IGnT may be largely 
responsible for the synthesis of soluble milk I-antigens [180]. All three IGnT forms consist of 
three exons and possess a different exon 1 but identical exon 2 and 3 coding regions. 
Mutations found in exons 2 and 3 abolish the branching activity of all three IGnTs and cause 
the i phenotype in erythrocytes [180-182]. 
The mouse I locus codes also three transcript forms, designated IGnTA, IGnTB, and 
IGnTC, which have three exons and share the second and third exons [183-185]. The mouse 
and human IGnT proteins have homologous amino acid sequences, and the pairs mIGnTB and 
hIGnTA (IGnT2), mIGnTA and hIGnTB (IGnT1), and mIGnTC and hIGnTC (IGnT3), show 
the highest identities [185]. 
Table 2 shows the relative reactivities of different acceptors with the comprehensively 
characterized cIGnTs. The relative reactivities with rat serum cIGnT are shown in Table 4, 
section 4.1. Generally, a complete LacNAc residue bound to the acceptor galactose residue is 
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required for cIGnT activity. The purified hog small intestine cIGnT and the cloned cIGnTs 
are capable to synthesize multiply branched PLNs. The partially purified rat intestine cIGnT 
differs from the other cIGnTs by reacting poorly with the reducing end galactose (underlined)  
in GlcNAcβ1-3LacNAcβ1-3Gal-R and LacNAcβ1-3LacNAcβ1-3Gal-R acceptors. 
 
Table 2. Relative reactivities of different acceptor oligosaccharides with purified and cloned 
cIGnTs. 
a)The abbreviations used are: LN=Galβ1-4GlcNAc, LNB=Galβ1-3GlcNAc, pNP=para-nitrophenol. Underlines 
indicate the reaction site of cIGnT. b)R=Glc-PA (PA, 2-aminopyridine), R=Glc for the values in brackets. 
c)R=GlcNAc, R=Glc-PA for the values in brackets. d)Calculated from data presented in [177]. e)R=GlcNAcβ1-
6Manα1-6Manβ1-octyl. f)R=Glc, R=GlcNAc for the values in brackets. g)Relative amounts of products were not 
determined exactly, but it was concluded that in major monobranched product the branch occur in middle Gal. 
-: activity not detected, blank: information not available. 
 
The cIGnT activity of rat serum is inhibited if either of the adjoining GlcNAc residues 
of the branch accepting Gal is α1,3-fucosylated [186]. Similar specificity is present in human 
IGnT1 (publication III, this thesis) and mouse IGnTA and IGnTB [184]. Terminal α2,3-
linked sialic acid abolishes the activity of the rat intestine enzyme [123] and diminishes the 
activity of mouse IGnTA and IGnTB [184]. Surprisingly, Neu5Acα2,6-substituted acceptors 
are efficiently branched by IGnTA and IGnTB [184]. Rat intestine and hog gastric cIGnTs 
show no reactivity, and IGnTA and IGnTB react weakly with Galβ1-3GlcNAcβ1-3Galβ1-4R 
Acceptora) cIGnT 
purified from 
rat intestineb) 
cIGnT 
purified from 
hog small 
intestinec,d) 
IGnT1 
cloned from 
human PA1 
cellse) 
IGnTA 
cloned from 
the mousef) 
IGnTB 
cloned from 
the mousef) 
Galβ1-4R -   (<1) (<1) 
GlcNAcβ1-3Galβ1-4R 7 (-) 6 9 2 
LNβ1-3Galβ1-4R 100 (92) 100  100 100 100 
LNBβ1-3Galβ1-4R - (-) (-)  4 6 
GlcNAcβ1-3LNβ1-3Galβ1-4R 9 50 59 22 41 
GlcNAcβ1-3LNβ1-3Galβ1-4R 11 - - - - 
GlcNAcβ1-3LNβ1-3Galβ1-4R  - 2 - - 
LNβ1-3LNβ1-3Galβ1-4R 6 21 18   
LNβ1-3LNβ1-3Galβ1-4R 121 32 46  170 (194) g) 181 (164) g) 
LNβ1-3LNβ1-3Galβ1-4R  7 20   
LNBβ1-3LNβ1-3Galβ1-4R    6 10 
Neu5Acα2-6LNβ1-3Galβ1-4R    256 148 
Neu5Acα2-3LNβ1-3Galβ1-4R -   48 33 
Fucα1-3LNβ1-3Galβ1-4R    3 2 
Galα1-3LNβ1-3Galβ1-4R    35 123 
GalNAcα-pNP    <1 <1 
Galβ1-3GalNAcβ1-4Galβ1-4R -     
GlcNAcβ1-3/6GalNAcα-pNP    <1 <1 
GlcNAcβ1-3(Galβ1-6)GalNAcα-pNP   <1 <1 
Reference [123] [177] [142] [184] [184] 
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acceptors that contain a terminal type 1 unit [123, 177, 184]. Branching of internal 
GalNAcβ1-4GlcNAc determinants in polylactosamines has been demonstrated with rat serum 
and IGnT1. However, the IGnT1 activity to internal GalNAcβ1-4GlcNAc unit is quite low as 
compared to LacNAc unit [187]. 
 
 
1.5 Structural analysis of polylactosamines by NMR spectroscopy 
 
Nuclear magnetic resonance (NMR) is a phenomenon that occurs when the nuclei of certain 
atoms are immersed in a static magnetic field and exposed to radio frequency electromagnetic 
radiation [188, 189]. Nuclei, such as 1H and 13C, possess a property called spin that generates 
a nuclear magnetic moment. In a magnetic field, magnetic moments are aligned with the field 
(lower energy) or against the field (higher energy). The magnetic moments at the lower 
energy level are excited into the higher level with electromagnetic radiation. The frequency of 
radiation needed is determined by the difference in energy between the energy levels. The 
magnetic field at the nucleus is not equal to the applied magnetic field; electrons around the 
nucleus shield it from the applied field. Therefore, nuclei that are chemically nonequivalent 
experience the external field slightly differently and resonate at different frequencies. The 
chemical shift of a nucleus is the difference between the resonance frequency of the nucleus 
and a standard, relative to the standard. This quantity is reported in parts per million (ppm) 
and given the symbol delta, . Nuclei that are connected through chemical bonds, typically 
less than or equal to three bond lengths, effect to each other's spin states. This effect is called 
spin-spin coupling or J coupling, and it shows up in the NMR spectrum as splitting of lines 
when the nuclei are nonequivalent i.e. have different chemical shifts. The distance between 
two split absorption lines is called the J coupling constant or the spin-spin splitting constant 
(Hz) and is a measure of the magnetic interaction between two nuclei. The 1H signal 
intensities i.e. the integrals of the signal curves in the spectrum give the ratios of the protons 
in the molecule. For 13C the signal intensities are often not given. This is because the natural 
abundance and sensitivity of 13C is much lower than 1H (1.11% and 99.98%, respectively), 
and detection methods used to improve the sensitivity of 13C give inaccurate signal intensities. 
The next sections deal mainly with the NMR techniques used in this study. 
 
 
1.5.1 One-dimensional 1H NMR spectroscopy 
 
A 1D 1H NMR spectrum can be recorded from a 1-10 nmol oligosaccharide sample. The 
oligosaccharides are usually dissolved in D2O for recording. In D2O, the OH protons and the 
NH protons of N-acetyl groups exchange to deuterons and give no signal. The residual HDO 
in the solution gives water signal that can be suppressed. The WEFT (water eliminated 
Fourier transform) technique [190] is well suited for water suppression in polylactosamine 
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NMR spectroscopy. Acetone is usually used as an internal standard, and the signals are 
referenced to the acetone signal at 2.225 ppm.  
Most of the protons of the oligosaccharides resonate between δ=3.4-3.9 ppm. This 
region of overlapping resonances is called the bulk-region, and these signals usually cannot be 
assigned. The protons not resonating in this region are referred to as structural reporter 
groups. In many cases, the assignment of these signals and their comparison to reference 
compounds is sufficient for the identification of the oligosaccharide structure. Α proton in the 
equatorial position at a certain carbon in a pyranose ring resonates at a ~0.5 ppm lower field 
than the corresponding axial proton. Therefore a H-1 involved in an α-glycosidic linkage 
resonates at ~4.9-5.6 ppm and in β-glycosidic linkage at 4.3-4.8 ppm. The coupling constant 
3J1,2 for axial H-1 and H-2 protons in β-gluco- and β-galacto-configuration is ~7-8 Hz. 
Instead, the 3J1,2 for equatorial H-1 and axial H-2 protons in α-gluco-, α-galacto-, and β-
manno-configuration, or for equatorial H-1 and H-2 protons in α-manno-configuration, is 3-4 
Hz. Thus α- and β-glycosidic linkages of Glc and Gal, but not for example Man, can also be 
inferred from 3J1,2 [191]. 
The expansion of the 1D 1H NMR spectrum of the pentasaccharide Galβ1-
4GlcNAcβ1-3(GlcNAcβ1-6)Galβ1-4GlcNAc in Figure 5 shows the typical reporter group 
signals of branched polylactosamines (published in [176, 192]). The presence of the 
GlcNAcβ1,6-linkage, not β1,2-linkage, in this pentasaccharide was firmly established by a 
series of one- and two-dimensional NMR experiments [192].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Expansion of 1H NMR spectrum of the branched pentasaccharide. The two H-1 signals of 
GlcNAc 3 arise from the α- and β-pyranosic forms of the oligosaccharide. The signals marked by an 
asterisk arise from the reducing end ManNAc epimer.  
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Different monosaccharide residues linked to polylactosamines can also be determined 
by 1D 1H NMR spectroscopy. For example, the constituents of sLex, Fucα1,3 and 
Neu5Acα2,3 residues, have characteristic structural reporter group signals: Fuc H-1, H-5, and 
H-6, and Neu5Ac H-3 (both axial and equatorial) [193]. The H-1 protons of terminal type 1 
unit, Galβ1-3GlcNAc, resonate at the same regions as the H-1’s of Galβ1-4GlcNAc, but the 
H-1 of Gal resonates at upper field and the H-1 of GlcNAc at lower field in type 1 unit 
(publication IV, and references therein). 
 
  
1.5.2 Two-dimensional NMR spectroscopy 
 
The structural identification of an oligosaccharide is not possible by 1D 1H NMR 
spectroscopy in cases where not all structural reporter groups can be assigned, or the 
assignments do not unambiguously determine the structure. By the use of two-dimensional 
1H-1H NMR techniques, TOCSY (total correlation spectroscopy) [194] and COSY (correlated 
spectroscopy) [195, 196] or DQFCOSY (double quantum filtered COSY) [197], almost all 
proton signals can be assigned. The completely assigned proton spectrum determines the 
linkage position to a certain ring carbon, as the proton resonance at that position is shifted 
downfield [191]. However, other protons nearby may also be shifted, and therefore these 
methods alone do not firmly establish the structure. To identify the structure unambiguously 
the two-dimensional 1H-13C NMR techniques are used. The HMQC (heteronuclear multiple 
quantum coherence) [198, 199] and HSQC (heteronuclear single quantum coherence) [200] 
spectra indicate carbon-proton linkages i.e. the 13C signals can be assigned by these methods. 
The downfield shift (5-10 ppm) of a 13C resonance indicates a glycosidic linkage to this 
carbon [191]. HMBC (heteronuclear multiple bond correlation) determines 1H-13C couplings 
through two or three bonds [200, 201]. HMBC technique is the best choice when enough 
sample (~0.5 µmol in the nanoprobe) is available because both the sequence and substitution 
positions can be determined unambiguously by this method. 
 
 
1.6 Biological functions that involve polylactosaminoglycans 
 
Selectins, a class of C-type (Ca2+-dependent) lectins, and galectins (formerly called S-type 
lectins) mediate cell adhesion by recognizing carbohydrate ligands. Selectins bind to capping 
groups of (poly)lactosamines, whereas galectins bind β-galactosides. Sperm-egg binding in 
fertilization involves carbohydrates. Many microorganisms exploit host cell-surface 
glycoconjugates as receptors for cell adhesion. Some pathogens have binding activity to 
(poly)lactosamines and/or their terminal substituents. 
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1.6.1. Selectin mediated cell adhesion 
 
The reaction cascade that leads to the extravasation of leukocytes from the bloodstream into 
inflamed tissue and lymphocyte homing to lymph nodes is initiated by selectin-carbohydrate 
interactions, reviewed in [202]. Inflammatory stimuli induce E- and P-selectins to appear on 
the surface of the vascular endothelium, and activation of platelets releases the granule-stored 
P-selectin to the surface of platelets. E- and P-selectins bind to their ligands on leukocytes, 
whereas L-selectin, which is constitutively expressed on leukocytes, binds to glycans on 
endothelial cells and on other leukocytes. The selectins mediate the tethering and rolling of 
leukocytes along the vessel wall, which is followed by firm adhesion, and penetration of the 
cells through the vascular wall. In a similar fashion, L-selectin mediates the initial attachment 
of lymphocytes to lymph node high endothelial venules (HEV) during lymphocyte 
recirculation.  
The HEV of lymph nodes express several mucin-like glycoprotein ligands for L-
selectin [203]. These ligands need to be sialylated, fucosylated, and sulfated for optimal 
binding to L-selectin [203-205]. O-glycan structures of mouse glycosylation-dependent cell 
adhesion molecule-1 (GlyCAM-1), the best characterized L-selectin-ligand, have been 
analyzed in detail. The simplest monosulfated O-glycans contain 6-sulfo-sLex and 6’-sulfo-
sLex epitopes on core 2 (Figure 6). These glycans account for less than 25% of the O-linked 
chains and the rest of the chains are more complex structures and may present multiple sLex 
and 6/6’-sulfo-sLex epitopes [206]. Oligosaccharide analysis of MECA-79 positive (Galβ1-
4(6-sulfo)GlcNAcβ1-3Galβ1-3GalNAc) GlyCAM-1 has indicated that O-glycans bear twin 6-
sulfo-sLex on biantennary core 2 in addition to 6-sulfo-sLex on core 2 (Figure 6) [207]. 
Lymphocyte homing is markedly reduced in mice lacking a HEV-restricted GlcNAc-6-O-
sulfotransferase (designated HEC-GlcNAc6ST or LSST) indicating that GlcNAc-6-sulfation 
is significant for L-selectin ligand activity [205].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Three O-glycans on GlyCAM-1.  
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CD34 is another L-selectin glycoprotein ligand on HEV. CD34 on human tonsillar HEV carry 
a sulfated and fucosylated O-glycan, which putatively has biantennary core 2 structure where 
6-sulfo-sLex is linked to core galactose [208]. L-selectin binds to sLex or its sulfated 
derivatives with a relatively low affinity [203, 209]. High affinity L-selectin ligands may be 
generated by O-glycans, which are presented on the protein backbone in unique spacing 
and/or clustered combinations [209, 210]. 
Inflammation in rejecting solid organ transplants is characterized by heavy infiltration 
of lymphocytes into the graft [211, 212]. During the acute rejection of rat kidney or cardiac 
allograft, the graft endothelium begins to express sialyl Lewis x oligosaccharides, which 
support L-selectin-dependent lymphocyte adhesion [213, 214]. The expression of L-selectin 
ligands, sLex and sulfo-sLex, is also induced in rejecting human allografts [215, 216] and in 
various inflammatory diseases [217, 218]. The expression patterns of sLex and sulfo-sLex are 
different between different inflamed tissues, suggesting that every organ expresses a specific 
‘zip code’ which regulates leukocyte traffic to that given organ [218]. 
 Enzymatically synthesized multivalent sLex polylactosaminoglycans at very low 
concentrations inhibit L-selectin-mediated lymphocyte binding to the endothelium of 
rejecting organ transplants and to lymph nodes of rats [214, 219-223]. Linear and branched 
tetravalent sLex glycans (Figure 7) are effective in inhibiting lymphocyte adhesion to 
activated cardiac epithelium, the IC50-values being around 1 nM in an ex vivo Stamper-
Woodruff binding assay [221]. Multivalency enhances the inhibitory effect of sLex glycans; 
multivalent sLex glycans are much better inhibitors than monovalent sLex tetrasaccharide 
[214, 220, 222]. A divalent sLexLex glycan (Figure 7) inhibits lymphocyte binding to cardiac 
allograft with an IC50 value of 5 nM and to lymph node endothelium with a ten times higher 
IC50 value [223]. This suggests that divalent sLexLex glycan and other L-selectin 
oligosaccharide antagonists may inhibit lymphocyte traffic to the site of inflammation without 
significantly altering the normal lymphocyte recirculation via lymph nodes. 
 
 
 
 
 
 
 
 
 
The best characterized ligand for P-selectin is P-selectin glycoprotein ligand-1 (PSGL-
1), which also interacts with L- and E-selectins. O-glycans on PSGL-1 from the 
promyelocytic cell line HL-60 contain two species of fucosylated and sialylated structures: 
one having sLex-Lex-Lex on core 2 branch, and the other having sLex on core 2 branch and 
Neu5Acα2,3 residue on core galactose [11]. The latter structure at Thr-57 of the protein 
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Figure 7. Examples of enzymatically synthesized biologically active oligosaccharides.  
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backbone and sulfation of three tyrosine residues (Tyr-46, -48, and -51) are necessary for high 
affinity binding of PSGL-1 to P-selectin [224-226]. The optimal L-selectin binding to PSGL-
1 and leukocyte rolling requires sialylated and fucosylated core 2 O-glycans attached to Thr-
57 and sulfation of Tyr-46 and -51 [227]. E-selectin binding to PSGL-1 does not require 
sulfation, but is dependent of sialylated and fucosylated, likely core 2 based O-glycans [228]. 
In contrast, N-linked glycans with sLex-like structures are essential for E-selectin binding to 
E-selectin ligand-1 (ESL-1) [229-231]. 
 
 
1.6.2 Galectin mediated cell adhesion 
 
Galectins are widely distributed in all living organisms, and from mammals alone, fourteen 
galectins have been identified [232, 233]. Some galectins (Gals), such as Gal-1 and Gal-3, are 
expressed in many tissues and cell types. Others are restricted to specific tissues, such as Gal-
2 and Gal-7, which are expressed specifically in gastrointestinal tract and stratified epithelia, 
respectively [233]. The galectins are found mainly in the cytoplasm, but several are secreted 
from cells by an unusual mechanism and interact with appropriately glycosylated protein 
ligands at the cell surface or within the extracellular matrix [234]. For example, Gal-1 and -3 
bind to basement membrane laminin and integrins [235]. The galectins bind multivalently and 
are capable of cross-linking ligands [236]. Many essential functions, where galectins play 
roles in regulating cell-cell and cell-matrix adhesion, have been implicated. These include cell 
motility, growth, differentiation, and apoptosis, development and tumor metastasis [235, 237, 
238]. In addition, leukocyte turnover that is not associated with apoptosis has been shown to 
involve Gal-1; the binding of Gal-1 to leukocytes induces their phagocytic recognition [239]. 
Individual galectins differ significantly in their recognition of galactosyl residues 
within oligosaccharides. The oligosaccharide specificity of 13 galectins has been studied and 
the previous data reviewed in [240]. The galectins recognize both type 2 (Galβ1-4GlcNAc) 
and type 1 (Galβ1-3GlcNAc) disaccharides. Three OH-groups are required for galectin 
binding, i.e. 4-OH and 6-OH of Gal, and 3-OH or 4-OH of Glc(NAc) depending on the 
glycosidic linkage [240, 241]. Substitutions at 4-OH and 6-OH of Gal, for example with 
Neu5Acα2,6, abolish galectin binding. Le-type structures, such as Lex, Lea, and Leb, are not 
recognized by galectins either. Gal-3 has the highest affinity to type 1 (Lecβ1-3Lac) and type 
2 (LacNAcβ1-3Lac) saccharides. Gal-2 and Gal-7 strongly prefer type 1 saccharides (Lecβ1-
3Lac) to type 2 (LacNAcβ1-3Lac). Increase in the number of the repeating LacNAc units (1 
to 3 units) enhances the affinity of Gal-3, Gal-7, Gal-8, and Gal-9. In contrast, Gal-1 does not 
show any particular preference for repeated N-acetyllactosamine structures, although it has 
been previously identified as a binding protein of laminin (see section 1.2.4). Many of the 
galectins show increasing affinity for N-glycans when the branching number increases from 
mono- to bi-, tri- and tetraantennary glycans. The ‘glycoside clustering effect’ may be in some 
extent responsible for the enhanced affinity. LacNAcβ1,6-branches in polylactosamines may 
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be recognized by galectins. Galectin-3 has been shown to bind glycopeptides derived from 
adult erythrocytes better than those derived from cord erythrocytes [241]. 
 
 
1.6.3 Fertilization 
 
Mammalian egg cells are surrounded by an extracellular matrix called zona pellucida (ZP). In 
the fertilization process, sperm initially binds in a species-specific manner to the surface of 
ZP. The binding induces the sperm acrosome reaction, or cellular exocytosis, which leads to 
the exposure of the inner acrosomal membrane. Then the acrosome-reacted sperm penetrates 
through the ZP and fuses with the egg cell, reviewed in [242]. The mammalian sperm-egg 
interaction is most thoroughly studied in the mouse. Mouse ZP, like all mammalian ZPs, 
contains three major families of glycoproteins (ZP1, ZP2, and ZP3). The sperm recognizes 
and binds to glycans on ZP3 and undergoes acrosome reaction. The acrosome-reacted sperm 
likely binds to ZP2 and remains bound to ZP. Penetration through the ZP is probably achieved 
by a combination of sperm motility and enzymatic hydrolysis [242]. 
Mouse ZP2 and ZP3 carry tri- and tetraantennary N-glycans with variable amounts of 
lactosamine repeats. Considerable amount of the glycans are acidic (95%): most are sialylated 
(80%) and a residual amount is sulfated. The desialylated N-glycans have terminal 
GlcNAcβ1-3, Galβ1-4, GalNAcβ1-, and Galα1-3 units, in a ratio of 63:31:4:2. The O-glycans 
of ZP3 have a trisaccharide structure GlcNAc-Galβ1-3GalNAc, reviewed in [243, 244]. 
Several studies have proposed the precise glycan sequences on ZP3 required to sperm 
binding, but the results are controversial. Candidates that participate in binding are glycans 
terminated either with α1-3 or β1-4 linked Gal, or with β1-3 linked GlcNAc, reviewed in 
[243, 244]. In recombinant ZP3, two vicinal O-linked oligosaccharides are essential for high 
affinity sperm binding. On the other hand, removal of N-glycans from intact egg cells results 
in decreased sperm binding. It is possible that N-linked glycans induce a conformation of ZP3 
necessary for the presentation of the essential O-glycans [244].  
Various exogenous oligosaccharides are able to inhibit mouse sperm-egg binding. The 
enzymatically synthesized tetravalent oligosaccharide with terminal LacNAc or Galα1-3 units 
(corresponds the branched tetravalent sLex structure in Fig. 7, page 23, without Fucα1,3 and 
Neu5Acα2,3 residues) inhibits binding by 80-90% at a concentration of 4-10 µM [245]. 40-
60% inhibition of binding is achieved with LacNAcβ1-3GlcNAc and Galα1-3LacNAc at 
concentrations 10-70 µM, and with their α1,3-fucosylated counterparts at <1µM 
concentrations [246]. Notably, fucosylated ZP-glycans have not been characterized from 
mouse [244]. 
Human sperm binding to ZP can be inhibited by various fucosylated and/or sialylated 
oligosaccharides such as sialyl Lewis x and glycoproteins such as glycodelin-A, reviewed in 
[244]. Glycodelin-A carries biantennary N-glycans whose terminal ends comprise of 
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LacdiNAc (GalNAcβ1-4GlcNAc) and in lesser extent LacNAc units that can also be α1,3-
fucosylated or α2,6-sialylated [247].  
 
 
1.6.4 Microbe adhesion 
 
Many pathogens bind to specific carbohydrate structures on the host cell surface. 
Helicobacter pylori that causes gastric ulcers and cancer has binding activity to Lecβ1-
3Lacβ1-Cer and Lewis b antigen present on human gastric epithelium [109, 248]. In addition, 
H. pylori binds to α2,3-sialylated PGCs from human erythrocytes [249]. Some H. pylori 
strains carry partially fucosylated PLNs in the O-antigen chains of the lipopolysaccharides. 
The PLNs contain internal Lex units and terminal Lex or Ley units, depending on the strain 
[2, 250]. By expressing Lewis epitopes that are also expressed in normal gastric tissue [251], 
H. pylori may camouflage from the host and survive in this way in gastric environment [2]. It 
is also possible that H. pylori binds through a Lex-Lex interaction i.e. the interaction of the 
Lex units in O-antigen chains with Lex units on host cell surface [250]. 
Escherichia coli heat-labile enterotoxin is able to bind terminal LacNAc units of 
LacNAcβ1-3Lacβ1-Cer, PGCs, and glycoproteins [252]. A certain E. coli strain binds to 
terminal GlcNAc units of PLNs on erythrocytes [253]. Plasmodium falciparum malaria 
parasites invade human erythrocytes by binding to sialylated, likely Neu5Acα2,3-linked, 
glycans [254, 255]. Mycoplasma pneumoniae and Streptococcus suis have binding activity to 
α2,3-sialylated PLNs on erythrocytes [256, 257]. Pseudomonas aeruginosa is able to bind 
both type 1 and type 2 disaccharide determinants [258]. 
Fucosylated oligosaccharides of human milk inhibit the binding of several pathogens 
and bacterial toxins such as Campylobacter jejuni and heat stable enterotoxin of E. coli to 
their host cells [259]. Thus, human milk oligosaccharides may block infection in infants by 
interfering with adhesion and binding events for bacterial colonization and infection. 
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2. AIMS OF THE STUDY 
 
The aims of the present study were: 
1. To study the substrate specificity of the centrally acting β1,6-N-acetylglucosaminyl-
transferase activity present in rat serum. 
2. To enzymatically synthesize multiply branched polylactosamines to serve as precursors for 
a potential L-selectin oligosaccharide antagonist.  
3. To study the acceptor specificity of a β1,6-N-acetylglucosaminyltransferase cloned from 
the human embryonal carcinoma cell line PA1. 
4. To study the acceptor specificity of the β1,3-galactosyltransferase activity present in the 
human colon adenocarcinoma cell line.  
5. To study the capability of the centrally acting β1,6-N-acetylglucosaminyltransferase 
activity to branch polylactosamines that contain a terminal type 1 unit. 
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3. MATERIALS AND METHODS 
 
3.1 Acceptor saccharides 
 
For the numbered structures (except 20) see Tables 4 and 5 and Figure 8 in part 4. 
The radiolabeled acceptors used in publication I were obtained as follows: acceptors 1 
and 2 were enzymatically synthesized as described in [175] and (I), acceptors 5-7 were 
obtained from metabolically labeled embryonal carcinoma cells [260, 261], acceptor 3 was 
obtained by incubating glycan 6 with UDP-Gal and β4Gal-T, and acceptor 4 by incubating 
glycan 5 with UDP-GlcNAc and β3Gn-T [175]. The unlabeled acceptors 1, 2, and 3 were 
synthesized from LacNAc (Sigma) by stepwise β3Gn-T and β4Gal-T reactions. Acceptor 20 
LacNAcβ1-3Lexβ1-3LacNAc (Lex is Galβ1-4(Fucα1-3)GlcNAc) used in publication II was 
synthesized as follows: GlcNAcβ1-3Lexβ1-3LacNAc was synthesized enzymatically from 
glycan 2 [262] and converted to radiolabeled glycan 20 by incubation with UDP-[3H]Gal and 
β4Gal-T. Acceptors used in publication III were synthesized as described: acceptor 6 [263], 
acceptor 3 [264], acceptor 21 (II), and LacNAcβ1-3Lex [265]. In publication IV, acceptor 24 
was synthesized from GlcNAcβ1-3Galβ1-OMe (Sigma) by stepwise β4Gal-T and β3Gn-T 
reactions, radiolabeled acceptors 25 and 27 were synthesized as described in [266] and [263]. 
Unlabeled acceptors 2 and 6 were synthesized as above and acceptor 26 was purchased from 
Sigma. 
 UDP-Gal and UDP-GlcNAc were from Sigma (MO, USA). UDP-[3H]Gal and UDP-
[14C]Gal were from Amersham (UK). 
 
 
3.2 Expression and purification of GST-IGnT1  
 
The β1,6-N-acetylglucosaminyltransferase (IGnT1, EC 2.4.1.150) from the human cell line 
PA1 was previously cloned and sequenced [178]. Construction, expression, and purification 
of a functional recombinant glutathionesulfotransferase (GST)-IGnT fusion protein that 
represents the stem and Golgi lumenal regions (amino acids 26-400) of native IGnT1 is 
described in publication III. 
 
 
3.3 Enzyme catalyzed transferase reactions 
 
Human serum β1,3-N-acetylglucosaminyltransferase (β3Gn-T) and bovine milk β1,4-
galactosyltransferase (β4Gal-T, EC 2.4.1.90, Sigma) reactions were carried out essentially as 
described in [263] and [133]. β1,6-N-acetylglucosaminyltransferase (IGnT) reactions are 
described in publications as follows: rat serum IGnT (I, IV), human serum IGnT (I) and 
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recombinant GST-IGnT1 (III). Human colon adenocarcinoma cells (Colo 205) were grown 
and lyzed, and used in β1,3-galactosyltransferase (β3Gal-T) reactions as described in (IV). 
 
 
3.4 Degradative reactions 
 
Enzymatic hydrolysis with jack bean (exo)-β-galactosidase (EC 3.2.1.23, Sigma) and endo-β-
galactosidase from Bacteroides fragilis (EC 3.2.1.103, Boehringer Mannheim, Germany) 
were performed as described in [261] and [175]. Diplococcus pneumoniae β-galactosidase 
(EC 3.2.1.23, Boehringer Mannheim) reactions were carried out as described in [267]. Partial 
acid hydrolysis and mild acid hydrolysis were carried out as described in [267] and [268]. 
 
 
3.5 Chromatographic methods 
 
Table 3. Chromatographic methods used in publications I-IV. 
 
Method Described in publication 
Desalting of reaction mixtures in a mixed bed of Dowex AG 1 (AcO-) 
and Dowex AG 50 (H+) 
 
I, III, IV 
Paper chromatography I, III, IV 
Size-exclusion chromatography on a Biogel P-4 column I 
Size-exclusion chromatography on a Superdex 75 HR 10/30 or 
Superdex peptide HR 10/30 column  
 
Ia), IIb), IVa) 
High-pH anion-exchange chromatography on a CarboPac PA-1 column I, IV 
a) Referenced to [138], b) referenced to [221] 
 
  
3.6 NMR spectroscopy 
 
NMR spectroscopy was performed in D2O at 500 MHz by Varian unity 500 spectrometer 
(Varian Inc., CA, USA). One-dimensional 1H NMR spectroscopy was carried out as described 
in publication I. Two-dimensional NMR experiments are described in IV.  
 
 
3.7 Mass spectrometry 
 
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF 
MS) was performed with a Vision 2000 (Finnigan MAT Ltd., UK) or BIFLEXTM (Bruker-
Franzen Analytic, Germany) mass spectrometer as described in publication I. 
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4. RESULTS 
 
4.1 Synthesis of multiply branched polylactosamines in vitro (I) 
 
The substrate specificity of the centrally acting β1,6-N-acetylglucosaminyltransferase(s) 
(cIGnTs) present in rat serum was studied by incubating polylactosamine acceptors with 
UDP-GlcNAc and rat serum. The structures of the acceptors and the products of the 
transferase reactions are shown in Table 4. 
The branching reaction of saccharide 1 (438 nmol) gave the doubly branched 
octasaccharide 10 (254 nmol) and the singly branched heptasaccharides 8 and 9 (78 nmol) 
almost in equal amounts. The products were isolated by size-exclusion chromatography on a 
Biogel P-4 column followed by separation of the saccharides 8 and 9 by HPAE 
chromatography. Reincubation of the heptasaccharides 8 and 9 with UDP-GlcNAc and rat 
serum gave octasaccharide 10. This established that octasaccharide 10 was generated via two 
different pathways: 1 −> 8 −> 10 and 1 −> 9 −> 10. Saccharide 10 was completely β1,4-
galactosylated by bovine milk β1,4-galactosyltransferase into the decasaccharide LacNAcβ1-
3(LacNAcβ1-6)LacNAcβ1-3(LacNAcβ1-6)LacNAc (11), the smallest possible prototype of a 
naturally occurring multiply branched polylactosaminoglycan backbone. A preparative scale 
branching reaction of saccharide 2 gave the singly branched hexasaccharide 12 and a small 
amount of the doubly branched heptasaccharide 14, but not the singly branched 
hexasaccharide 13. The branch in hexasaccharide 12 induced some reactivity of the 
subterminal Gal; reincubation of hexasaccharide 12 converted it to heptasaccharide 14. All 
reaction products were identified by MALDI-TOF MS and 1D 1H NMR spectroscopy.  
A panel of radiolabeled acceptors (1-7), obtained by enzymatic synthesis and from 
metabolically labeled embryonal carcinoma cells [260, 261], were incubated with UDP-
GlcNAc and rat serum to define the minimal optimal sequence for the cIGnT reaction. The 
unreacted acceptors and the products were separated by paper chromatography. The position 
of the branch(es) in products 8-10, 12, 14, and 15 were established by subjecting them to 
(exo)-β-galactosidase (Jack bean) and endo-β-galactosidase (Bacteroides fragilis) digestion 
and subsequently identifying the cleavage products by paper chromatography. Partial acid 
hydrolysis of saccharide 10 further confirmed that both midchain galactoses were branched.   
The relative reactivities of the acceptors, shown in Table 4, indicate that the LacNAcβ1-
3LacNAc sequence is the binding epitope for cIGnT(s). The poor reactivity of the subterminal 
galactoses of acceptors 2, 4, 6, and 7 indicate that rat serum does not contain significant 
dIGnT activity. Activity to terminal galactoses, tIGnT activity, was not detected either. 
The sera of several mammalian species was shown to contain cIGnT activity with 
similar acceptor specificity to the one in rat serum cIGnT(s). 
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Table 4. Structures of the acceptors and the products obtained in reactions catalyzed by the 
rat serum cIGnT activity. The relative reactivities of the individual acceptor sites are also 
shown. 
 
Acceptor 
(acceptor site is underlined) 
Relative 
reactivitya
Product(s) 
 
 
 
 
 
 
 
 
 
 
a Relative reactivities of the acceptors were compared in parallel experiments with equimolar samples of the 
reference pentasaccharide 2. b The data were calculated by taking into account that octasaccharide 10 carried 
branches in both midchain galactoses, while in 8 and 9 the branch was present either in reducing LacNAc (43%) 
or middle LacNAc (57%) unit. c The relative reactivities of the midchain galactoses are included in the data of 
glycans 8 and 9. d The location of the branch was not established. 
120b
150b
c
5
0
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc    (8)
Galβ1-4GlcNAcβ1 3
GlcNAcβ1 
6
100
0
0
200
12d
20
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (1)
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc   
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc   
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (10)
Galβ1-4GlcNAcβ1 3
GlcNAcβ1 
6GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc    (9)
Galβ1-4GlcNAcβ1 3
GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (2)
GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc   
GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc   
GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (14)
GlcNAcβ1 3
GlcNAcβ1 
6GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (13)
GlcNAcβ1 3
GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (12)
GlcNAcβ1 3
GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (3)
Galβ1-4GlcNAcβ1 3
Galβ1-4GlcNAc  (15)
GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Gal                      (4)
GlcNAcβ1 3
Galβ1-4GlcNAcβ1 3
Gal                     (16)
GlcNAcβ1 3
GlcNAcβ1 
6
Galβ1-4GlcNAcβ1 3
Gal                     (5)
Galβ1-4GlcNAcβ1 3
Gal                      (17)
GlcNAcβ1 
6
GlcNAcβ1 3
Galβ1-4GlcNAc  (6)
 
GlcNAcβ1 3
Gal                      (7)
GlcNAcβ1 3
Galβ1-4GlcNAc  (18)
GlcNAcβ1 
6
GlcNAcβ1 3
Gal                      (19)
GlcNAcβ1 
6
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4.2 Enzymatic synthesis of precursors for a L-selectin oligosaccharide antagonist (I,II) 
 
The successful synthesis of glycan 10 opened up an enzymatic synthesis route to a linear 
tetravalent sLex saccharide (Figure 7, page 23) that has been shown to be a nanomolar 
inhibitor of L-selectin-mediated adhesion of lymphocytes to activated endothelium [221]. 
Glycan 10 was converted by sequential β3Gn-T, distally acting IGnT, and β4Gal-T reactions 
into glycan 23 (Synthesis route A, Figure 8). The obtained backbone was further α2,3-
sialylated and α1,3-fucosylated into the tetravalent sLex glycan [221]. 
To simplify the synthesis route to glycan 23, the conversion of the linear 
octasaccharide LacNAcβ1-3LacNAcβ1-3LacNAcβ1-3LacNAc (21) by cIGnT into triply 
branched glycan 22 was considered (Synthesis route B, Figure 8). Acceptor 21 is available by 
chemical synthesis [269, 270], and this in turn would make the synthesis of glycan 22 
upscalable. However, it was not known whether cIGnTs are able to generate triply branched 
polylactosamines. To study this, the octasaccharide acceptor 21 was enzymatically 
synthesized from the heptasaccharide LacNAcβ1-3Lexβ1-3LacNAc (Lex is Galβ1-4(Fucα1-
3)GlcNAc) (20) by sequential human serum β3Gn-T and bovine milk β4Gal-T reactions and 
finally removing Fuc by mild acid hydrolysis. The fucosylated acceptor was used to prevent 
the action of cIGnT that is also present in human serum [175]. After each reaction step, the 
products were purified by size-exclusion chromatography followed by paper or HPAE 
chromatographies, and their structures were confirmed by MALDI-TOF MS and 1D 1H NMR 
spectroscopy. Incubation of glycan 21 with UDP-GlcNAc and the cIGnT activity present in 
rat serum gave several products that were separated by HPAE chromatography. The MALDI-
TOF mass spectrum of the principal product showed a major signal that was assigned to 
(M+Na)+ of Gal4GlcNAc7. The 1H NMR spectrum established the structure of triply branched 
undecasaccharide 22. Enzymatic β1,4-galactosylation of glycan 22 gave glycan 23, the 
precursor of tetravalent sLex glycan.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(21) (22) (23) 
Figure 8. The original synthesis route A and the novel, simplified synthesis route B to glycan 23. 
Abbreviations used are: GN, GlcNAc and LN, Galβ1-4GlcNAc. 
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4.3 The acceptor specificity of the centrally acting β1,6-N-acetylglucosaminyltransferase 
cloned from human embryonal carcinoma cell line PA1 (III) 
 
The cDNA coding for the β1,6-N-acetylglucosaminyltransferase (IGnT1) responsible for 
biosynthesis of branched polylactosamines in human PA1 cells was previously isolated, but it 
was not known whether it codes for a cIGnT or a dIGnT enzyme [178]. To determine the 
specificity of IGnT1, a fusion protein representing the catalytic ectodomain of the IGnT1 and 
glutathionesulfotransferase (GST) was expressed in Baculovirus-infected Sf9 insect cells. The 
functionality of the recombinant GST-IGnT1 was shown by incubating separately the 
acceptors LacNAcβ1-3LacNAc (3) and GlcNAcβ1-3LacNAc (6) with UDP-GlcNAc and Sf9 
cell lysate. Paper chromatography of the reaction products showed that tetrasaccharide 3 had 
been converted in significant amounts into putative LacNAcβ1-3(GlcNAcβ1-6)LacNAc (15), 
whereas acceptor 6 remained unchanged. The purified recombinant GST-IGnT1 also 
converted glycan 3 to glycan 15. MALDI-TOF MS confirmed the formation of the 
pentasaccharide product Gal2GlcNAc3. The structure of glycan 15 was initially characterized 
by (exo)-β-galactosidase (Jack bean) and endo-β-galactosidase (Bacteroides fragilis) 
digestions. The experiments showed that the new GlcNAc was not transferred to the terminal 
Gal, but to the internal Gal or GlcNAc residues. The 1H NMR spectrum of glycan 15 
complemented the data, confirming the structure of glycan 15. The GST-IGnT1 reaction with 
glycan 21 generated probably isomeric mono- and dibranched products according to MALDI-
TOF MS analysis of the reaction mixture. The fucosylated LacNAcβ1-3Lex acceptor was not 
branched in the transferase reaction. The acceptor specificity of GST-IGnT1 showed that it 
represents cIGnT type enzyme and resembles rat serum cIGnT in substrate specificity. 
 
 
4.4 Enzymatic synthesis of linear and branched polylactosamines containing terminal 
type 1 units (IV)  
 
A number of oligosaccharide acceptors were incubated with UDP-Gal and lysate of Colo 205 
cells known to contain β3Gal-T and β4Gal-T activities [155, 158, 271] (Panel A, Table 5). 
The β4Gal-T activities were inhibited by adding α-lactalbumin to the reaction mixture, and 
the residual β1,4-linked Gal residues were removed from the products with Diplococcus 
pneumoniae β-galactosidase. The products were purified by combining paper and HPAE 
chromatographies with size-exclusion chromatography. The purity of the β1,3-galactosylated 
products was established by MALDI-TOF MS, and their structures were identified by NMR 
spectroscopy. The linear acceptors 2, 24, and 6 were most efficiently β1,3-galactosylated, 
whereas acceptors 25 and 26 showed weak reactivity. Branch-specific activity was detected 
with acceptor 27, where the β1,3-linked GlcNAc was preferred over the GlcNAcβ1,6-branch. 
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Table 5. Panel A. Structures of the acceptors and the products obtained in reactions catalyzed 
by the β3Gal-T activity of Colo 205 cells. Panel B. Structures of the products obtained from 
acceptor 28 in cIGnT reaction of rat serum. 
 
 
An alternative synthesis route to branched polylactosamines with terminal type 1 unit 
was revealed. Incubation of Lecβ1-3LacNAcβ1-LacNAc (28) with UDP-GlcNAc and cIGnT 
activity of rat serum gave the doubly branched octasaccharide 34 (24%) and a mixture of 
singly branched heptasaccharides 35+36 (42%) (Panel B, Table 5) that were separated by 
paper chromatography. MALDI-TOF mass spectra of glycans 34 and 35+36 confirmed the 
molecular compositions of Hex3HexNAc5 and Hex3HexNAc4, respectively. 1D 1H NMR 
spectroscopy confirmed the structure of glycan 34 and glycans 35+36, and showed the 
presence of both heptasaccharides in almost equal amounts. Lecβ1-3LacNAc (30) and 
LacNAcβ1-3LacNAc (3) as a control were subjected in parallel to branching reactions. 
MALDI-TOF mass spectra revealed that 55% of glycan 30 was converted into a 
pentasaccharide Gal2GlcNAc3, whereas glycan 3 was totally branched to a pentasaccharide. 
The results suggest that at least the cIGnT type enzymes can branch Lecβ1-3LacNAcβ1-OR 
type glycans. 
 
 
4.5 Structural analysis of the products by NMR spectroscopy (I-IV) 
 
The 500 MHz 1H NMR spectra of the products 8-12 and 14 fully confirmed the structures 
predicted from the degradative tracer experiments (I). The spectrum of glycan 8 showed the 
H-1 signal of the β1,6-linked GlcNAc at 4.585 ppm, which was identical to the corresponding 
signal in LacNAcβ1-3(GlcNAcβ1-6)LacNAc (15) reported in [176, 192]. The spectrum of 
glycan 9 showed the H-1 signal of the β1,6-linked GlcNAc at 4.593 ppm, which corresponded 
Panel A            Acceptors       β1,3-galactosylated products  
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Panel B                                                     GlcNAcβ1,6-branched products 
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 35
to the H-1 signal of the analogous residue in GlcNAcβ1-3(GlcNAcβ1-6)LacNAcβ1-3LacNAc 
[167]. The spectrum of glycan 10 showed two H-1 signals of β1,6-linked GlcNAc residues at 
4.585 ppm and at 4.593 ppm, revealing the presence of GlcNAcβ1,6-branches at both 
midchain galactoses. Branching caused marked changes in the structural reporter group 
signals of the main chain. The H-1 and H-4 signals of the galactoses in acceptor 1 were 
consistently shifted upfield when branched. A similar upfield shift has also been reported for 
GlcNAcβ1-3(GlcNAcβ1-6)LacNAc sequence [164]. GlcNAcβ1,6-branching of the reducing 
end LacNAc unit regularly shifts the H-1 resonance of the reducing end GlcNAc downfield 
[164, 192]. The H-1 signal of the terminal Gal was not affected by branch formation. The 
β1,4-galactosylation of glycan 10 gave glycan 11. The spectrum of glycan 11 revealed a new 
doublet of two protons at 4.465 ppm, which were assigned to the H-1’s of the branch-
galactoses in accordance with the analogous H-1 resonance of the branch-galactose in 
LacNAcβ1-3(LacNAcβ1-6)LacNAc [272]. The spectra of glycans 12 and 14 agreed in 
relevant parts with the spectra of glycans 8 and 10. In addition, the spectrum of glycan 14 was 
practically identical to the spectrum of the analogous glycan where the distal branch was 
synthesized by dIGnT activity of hog gastric microsomes and the central one by cIGnT 
activity of rat serum [167]. 
All structures along the synthesis route from LacNAcβ1-3Lexβ1-3LacNAc (20) to 
LacNAcβ1-3LacNAcβ1-3LacNAcβ1-3LacNAc (21) were established by 1D 1H NMR 
spectroscopy (II). Glycan 21 was converted into the triply branched glycan 22 by the cIGnT 
activity of rat serum. The spectrum of glycan 22 revealed three new protons, one at 4.585 
ppm and two at 4.593 ppm. The first one originates from the GlcNAcβ1-6 linked to the 
reducing end LacNAc unit, and the latter two from the GlcNAcβ1-6 residues linked to the 
midchain LacNAc units. The reporter group signals of glycan 22 were practically identical 
with their counterparts found in the spectra of the doubly branched glycan 10. The spectrum 
of the β1,4-galactosylated glycan 23 showed three H-1 signals of the newly transferred branch 
galactoses at 4.464 ppm, which corresponded to the signals of glycan 11. 
LacNAcβ1-3LacNAc was converted into LacNAcβ1-3(GlcNAcβ1-6)LacNAc (15) 
with the recombinant GST-IGnT1 enzyme (III). The 1H NMR spectrum of pentasaccharide 15 
showed practically identical structural reporter group signals with the authentic 
pentasaccharides synthesized by the cIGnT of rat serum [192] and PA1 cell lysate [179]. The 
similarity of the H-1 signal of the new GlcNAc residue and the H-1 and H-4 signals of the 
midchain Gal residue of saccharide 15 with the corresponding signals of authentic saccharides 
indicated that the new GlcNAc residue was β1,6-bonded to the midchain galactose. 
 1D 1H NMR spectra were recorded for the β1,3-galactosylated products (IV). 
However, the resonances of the putative Lec units differed from the corresponding signals 
reported for Lecβ1-3Lac [273] and when compared to the 1H chemical shifts of LacNAcβ1-
3Lac [273] the substitution with either Galβ1-3 or Galβ1-4 could not be confirmed. 
Therefore, the type 1 linkage (underlined) on Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-
3Galβ1-OMe (29) was unambiguously identified by the assignment of the 1H signals from 
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DQFCOSY and TOCSY spectra, and subsequently of the 13C signals from a HMQC 
spectrum. The C-3 resonance of the subterminal GlcNAc (83.35 ppm) was shifted downfield 
as compared to the resonance of unsubstituted GlcNAc (~70 ppm) indicating glycosidic 
linkage of type 1. The H-1 doublet of Galβ1-3 residue with the 3J1,2 coupling constant of 7.8 
Hz confirmed the β anomeric configuration. The unambiguous identification of glycan 29 
established the H-1 resonances of type 1 unit GlcNAc at 4.725 ppm and Gal at 4.441 ppm. 
The linear glycans 28 and 30 were identified from 1D 1H NMR spectra according to that data. 
The 1H NMR spectra of Lecβ1-6LacNAc/Lac, the linear glycans 31 and 32, showed the H-1 
signals of the reducing part (Rβ1-6LacNAc/Lac) that corresponded the signals recorded for 
their acceptor saccharides. The H-1 signals of the GlcNAcβ1,6 residues were similarly shifted 
downfield (~0.050 ppm) as the signals of the β1,3-galactosylated GlcNAcβ1,3 residues in 
glycans 28-30. Accordingly, the signals at 4.437 ppm (glycan 31) and 4.426 ppm (glycan 32) 
resonating upfield from 4.441 ppm were assigned as the H-1 signals of the β1,3-linked 
galactoses. The 1H NMR spectrum of Lecβ1-3(GlcNAcβ1-6)LacNAc, glycan 33, established 
that β1,3-linked GlcNAc in the acceptor 27 was β1,3-galactosylated. The H-1 resonances of 
type 1 unit were similar to those in glycans 28-30 and the resonances of the reducing part 
Rβ1-3(GlcNAcβ1-6)LacNAc were in accordance to those reported for LacNAcβ1-
3(GlcNAcβ1-6)LacNAc (15) [192]. 
The branching reaction of glycan 28 with rat serum cIGnT gave octa- and 
heptasaccharide products (IV). The 1D 1H spectrum of the octasaccharide 34 revealed the 
characteristic H-1 signal of Galβ1-3 at 4.440 ppm establishing the terminal type 1 linkage and 
excluding GlcNAc substitution of the nonreducing end Gal. The two H-1 signals of the β1,6-
linked GlcNAcs resonated exactly in the same positions as the corresponding signals of 
glycan 10 (I), confirming the structure of glycan 34. The spectrum of the heptasaccharide 
products showed that this material represented a mixture of isomeric glycans 35+36. Two 
doublets of nearly equal size in the area of H-1 signals of β1,6-linked GlcNAcs were similar 
to those originating from glycan 34, revealing the presence of almost equal amounts of 
products branched at midchain or reducing end LacNAc units. 
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5. DISCUSSION 
 
5.1 Centrally acting β1,6-N-acetylglucosaminyltransferases synthesize multiple branches 
on linear polylactosamines in vitro 
 
The cIGnT activity present in rat, human, and other mammalian sera was shown to convert 
hexasaccharide 1 into the doubly branched octasaccharide 10 via two distinct pathways: 1 −> 
8 −> 10 and 1 −> 9 −> 10 (I). The first GlcNAc branch transferred to acceptor 1 did not 
prevent the secondary branching reaction, which led to the octasaccharide 10. In addition, it 
was shown that the LacNAcβ1-3LacNAc sequence is required for efficient activity of 
cIGnT(s). The results suggest that cIGnT(s) interact with hexasaccharide 1 in the bimodal 
manner shown in Figure 9. The transferase reaction of rat serum cIGnT(s) with octasaccharide 
LacNAcβ1-3LacNAcβ1-3LacNAcβ1-3LacNAc (21) gave the triply branched 22 as a major 
product and minor products, which probably represented the isomeric singly and doubly 
branched products (II).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The fusion protein GST-IGnT1, representing the catalytic ectodomain of IGnT 
expressed in human PA1 cells, was functionally expressed, purified, and shown to have 
cIGnT activity (III). The lack of the cytoplasmic and membrane binding segment in the 
recombinant IGnT1 probably did not cause major changes in the substrate specificity, because 
PA1 cell lysates have been shown to contain cIGnT rather than dIGnT activity as well [179]. 
Recombinant IGnT1 converted octasaccharide 21 into mono- and dibranched products. The 
triply branched product was not formed as with rat serum, which was likely due to the small 
amount of the enzyme available. 
Figure 9. Postulated interaction of the hexasaccharide acceptor 1 with the cIGnT present in
mammalian serum. Interaction with site A leads to the formation of glycan 8 and interaction with site
B leads to the formation of glycan 9. The secondary branching reactions lead to glycan 10. 
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6
 38
At present, similar substrate specificity to mammalian serum cIGnT and GST-IGnT1 
has been reported for several other cIGnT enzymes. These include protein A-IGnT1, which is 
an analogue of GST-IGnT1 [142], the cloned mouse IGnTA and IGnTB [184], and cIGnT 
purified from hog small intestine [177] (Table 2, section 1.4.4.2). Protein A-IGnT1 has been 
shown to convert LacNAcβ1-3LacNAcβ1-3LacNAcβ1-6Manα1-6Manβ1-octyl into singly 
and doubly branched products, and branching was more favored at middle LacNAc unit. 
Similarly, the cloned mouse IGnTA and IGnTB also branch the middle LacNAc unit of 
LacNAcβ1-3LacNAcβ1-3Lac acceptor more efficiently than the reducing end Lac unit. In 
contrast, rat serum cIGnT (I) and cIGnT purified from hog small intestine [177] branch both 
midchain and reducing end LacNAc units in acceptor 1 equally well. It is not clear whether 
the different site specificities are due to the specificities of the enzymes or the acceptors used. 
N-acetyl group in the reducing end of the acceptor has been shown to enhance the human 
serum cIGnT activity; the relative reactivities of GlcNAcβ1-3LacNAcβ1-3LacNAc (2) and 
GlcNAcβ1-3LacNAcβ1-3Lac of 100 and 41, respectively, have been reported (the reacting 
units are underlined) [175]. On the other hand, for example α1,3-fucosyltransferases have 
different site specificities on linear polylactosamines [274].  
Rat serum did not contain significant amounts of dIGnT activity as there were no 
branching at the subterminal Gal of acceptor 2 and only minor amount of acceptor 6 was 
branched. However, the pre-branched glycan 12 was distally branched, yielding glycan 14, 
when it was reincubated with UDP-GlcNAc and rat serum. Protein A-IGnT1 also contains 
some dIGnT activity: it branches very weakly the subterminal Gal residue of the GlcNAcβ1-
3LacNAcβ1-6Manα1-6Manβ1-octyl acceptor [142] (see Table 2). Thus, cIGnTs may show 
minor dIGnT activity with certain acceptors. 
Fucosylation of polylactosamines has been shown to prevent the action of cIGnT of 
rat serum [186] and the cloned mouse IGnTA and IGnTB [184]. The recombinant GST-
IGnT1 could not branch the fucosylated acceptor LacNAcβ1-3Lex either (III). Hence, 
fucosylation and GlcNAcβ1,6-branching seem to be reciprocal in LacNAc units on 
polylactosamines. 
 The doubly branched glycan 10 was successfully converted with bovine milk β4Gal-T 
into LacNAcβ1-3(LacNAcβ1-6)LacNAcβ1-3(LacNAcβ1-6)LacNAc (11). Glycan 11 presents 
the smallest possible multiply branched sequence found in natural polylactosaminoglycans. 
Another biosynthesis route to multiply branched polylactosaminoglycans has been proposed 
by Ujita et al. In their model β1,6-N-acetylglucosaminyltransferase (IGnT1), β1,3-N-
acetylglucosaminyltransferase (iGnT), and β1,4-galactosyltransferase (β4Gal-T1) act 
sequentially, elongating and branching the growing chain in turn [142].  
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5.2 Branched polylactosamines as precursors for biologically active oligosaccharides 
 
The triply branched glycan 23, the precursor of the linear tetravalent sLex glycan (shown in 
Figure 7, page 23), has been initially synthesized from the hexasaccharide 10 by three 
enzymatic steps [221]. The improved synthesis route to glycan 23 involved the conversion of 
the linear octasaccharide 21 into the triply branched glycan 22 in a single-step transformation 
catalyzed by the cIGnT activity of rat serum and β1,4-galactosylation of glycan 22 into glycan 
23 (II) (Figure 8, page 32). Hence, the novel synthesis route was devoid of the laborious 
β3Gn-T and distally acting ΙGnΤ reactions. The major advantage in the use of the linear 
glycan 21 as a primer is that it is also accessible in considerable amounts by chemical 
synthesis in solution [269, 270]. The chemical synthesis of branched glycans related to glycan 
23 have also been presented [275, 276] suggesting that the chemical synthesis of glycan 23 
may also become available. Expression of the functional human IGnT1 (III) allows the 
branching reaction by a recombinant enzyme. At present, a repertoire of glycosyltransferases 
has been cloned, which should allow the whole synthesis of glycan 23 and its conversion into 
the linear tetravalent sLex glycan with recombinant enzymes. Thus, the availability of 
chemical, enzymatic, and hybridized chemo-enzymatic approaches should make the large 
scale synthesis of the tetravalent sLex glycan possible. This in turn, will lead to better 
assessment of the anti-inflammatory potential of the tetravalent sLex glycan in different in 
vivo inflammation models. Also its putative roles as antagonists of E- and P-selectins and 
other sugar-binding proteins will also merit a study. 
 
 
5.3 Biosynthetic pathways to polylactosamines with terminal type 1 unit  
 
The β3Gal-T activity of Colo 205 cells was shown to use both linear and branched 
polylactosamines as acceptors (IV). The β3Gal-T activity of Colo 205 cells is most likely due 
to β3Gal-T5 [158], but β3Gal-T1 and β3Gal-T2 may also be responsible in some part for the 
activity or activities [271]. In the branched acceptor GlcNAcβ1-3(GlcNAcβ1-6)LacNAc, the 
GlcNAcβ1,3-branch was strongly favoured over the GlcNAcβ1,6-branch. In contrast, β4Gal-
T of bovine milk has been shown to preferentially react at the GlcNAcβ1,6-branch in the 
corresponding acceptors [135-138]. The complementary branch specificities of β3Gal-T(s) 
and β4Gal-T are in accordance with the natural type 1-type 2 epitope structures, Lecβ1-
3(LacNAcβ1-6)LacNAc (Table 1, section 1.3). 
 An alternative route to branched polylactosamines with terminal type 1 disaccharides 
was shown by branching linear Lec[β1-3LacNAc]1 or 2 oligosaccharides with the cIGnT 
activity of rat serum (Scheme 1). It has been reported previously that the cIGnTs purified 
from rat and hog intestine do not branch Lecβ1-3Lac-PA under their reaction conditions [123, 
177], but the cloned mouse IGnTA and IGnTB have some reactivity to the Lac unit in Lecβ1-
3[LacNAcβ1-3]0 or 1Lac acceptors, although the products were not characterized [184]. 
 40
Human serum contains similar cIGnT activity to that of rat serum (I), suggesting that also 
human cIGnT(s) synthesize branches on type 1 polylactosamines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4 Structural determination of polylactosamines by NMR spectroscopy 
 
The linear type 2 polylactosamines were readily characterized by 1D 1H NMR spectra. The 1H 
structural reporter group signals of glycans ranging in size from two LacNAc units to four 
LacNAc units followed a similar pattern. Typical signals were obtained for reducing end 
GlcNAc and nonreducing end Gal residues. The H-1 signals of the internal GlcNAc residues 
and the H-1 and H-4 signals of internal Gal residues were practically identical in all LacNAc 
units. 
The newly formed type 1 linkage on linear polylactosamine was unambiguously 
identified by a series of 1D and 2D NMR experiments, and the 1H structural reporter group 
signals of the terminal type 1 unit were determined (IV). Comparison of the 1H structural 
reporter group signals of Lecβ1-3Lac [273] and Lecβ1-3LacNAc tetrasaccharides (IV) 
showed that Glc and GlcNAc at the reducing ends have different effects on the 1H resonances 
of the terminal type 1 units present in these tetrasaccharides. In contrast, the 1H structural 
reporter group signals of the distal LacNAc units in the type 2 tetrasaccharides LacNAcβ1-
3Lac [273] and LacNAcβ1-3LacNAc [192] are consistent with each other. This shows the 
importance of the production and unambiguous NMR analysis of each natural epitope as 
references for later 1D NMR works.  
In branched polylactosamines, ranging from singly to triply branched glycans, the H-1 
signal of the GlcNAcβ1,6 residue bound to the reducing end LacNAc unit resonated at 
distinct position from those bound to the middle LacNAc unit(s). When branch GlcNAcs were 
β1,4-galactosylated, all the H-1 signals of the branch Gals resonated at the same position, and 
the signals of GlcNAcβ1,6 residues were shifted downfield maintaining different resonances 
for reducing end and midchain LacNAc bound residues. The distinct chemical shifts have yet 
Scheme 1. Two proposed biosynthetic pathways leading to branched type 1 polylactosamines.
3 LacNAc 
GlcNAcβ1
3 
Galβ1 
3 LacNAc
GlcNAcβ1 
             GlcNAcβ1 3
GlcNAcβ1 
LacNAc 6
             GlcNAcβ1 3
GlcNAcβ1 
LacNAc 6
3 
Galβ1 
1. β3Gal-T 
2. cIGnΤ 
3. dIGnT
4. β3Gal-T  
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been observed when distal galactoses carry α2,3-bonded Neu5Ac residues [221]. These 
features provide possibilities to monitor the action of glycosyltransferases and glycosidases at 
distinct sites of branched, galactosylated, and sialylated glycans. 
In branched polylactosamines with terminal type 1 unit, ranging from singly to doubly 
branched glycans, the H-1 signal of the GlcNAcβ1,6 residues were in accordance with 
analogous type 2 polylactosamines. Thus, the only differences in the 1H structural reporter 
group signals were the signals of Galβ1-3GlcNAc unit. It is worth noting that in Galβ1-
3/4(GlcNAcβ1-6)GlcNAc-R structures the H-1 of GlcNAcβ1-6 residue resonate at the same 
position independently of the terminal linkage, Galβ1-3 or Galβ1-4. 
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